Results overview: Found 268 records in 0.01 seconds.
Articles, 103 records found
Contributions to meetings and congresses, 8 records found
Books and collections, 7 records found
Research literature, 67 records found
Learning materials, 2 records found
Course materials, 78 records found
Graphic and multimedia documents, 1 records found
Personal and institutional archives, 3 records found
Articles 103 records found  1 - 10nextend  jump to record:
1.
28 p, 351.4 KB El nacimiento del fútbol en España : ¿Cómo se entrenaba y cómo se jugaba? 1ª parte (1899-1920) / Pérez-Martínez, Carlos (Universitat Autònoma de Barcelona) ; Torrebadella-Flix, Xavier (Universitat Autònoma de Barcelona)
El fútbol es un gran fenómeno de masas a nivel mundial, un deporte que está en boca de todos día tras día, pero como todo, tuvo un comienzo. Con este artículo acercaremos al lector a los orígenes del fútbol en España desde su llegada a finales del siglo XIX, hasta 1920, año en el que la Selección española participó por primera vez en unos Juegos Olímpicos. [...]
2020
Recorde: Revista de História do Esporte, Vol. 13 Núm. 1 (2020)  
2.
17 p, 1.4 MB Mephedrone and Alcohol Interactions in Humans / Papaseit Fontanet, Esther (Department of Pharmacology, Therapeutics and Toxicology and Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona (UAB)) ; Pérez Mañá, Clara (Department of Pharmacology, Therapeutics and Toxicology and Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona (UAB)) ; de Sousa Fernandes Perna, Elizabeth B. (Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University) ; Olesti, Eulalia (Department of Health and Life Sciences, Universitat Pompeu Fabra (CEXS-UPF)) ; Mateus, Julian (Integrative Pharmacology and Systems Neuroscience Research Group, Neurosciences Research Program, IMIM-Hospital del Mar Medical Research Institute, Parc de Salut Mar) ; Kuypers, Kim PC (Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University) ; Theunissen, Eef L. (Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University) ; Fonseca Casals, Francina, 1972- (Institut de Neuropsiquiatria i Adiccions, Addiction Unit and IMIM) ; Torrens, Marta (Institut de Neuropsiquiatria i Adiccions, Addiction Unit and IMIM) ; Ramaekers, Jan G. (Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University) ; de la Torre, Rafael (CIBER de Fisiopatología de la Obesidad y Nutrición (CB06/03), CIBEROBN) ; Farré Albaladejo, Magí (Department of Pharmacology, Therapeutics and Toxicology and Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona (UAB))
Mephedrone (4-MMC, mephedrone) is a synthetic cathinone derivative included in the class of new psychoactive substances. It is commonly used simultaneously with alcohol (ethanol). The aim of the present study was to evaluate the interactions on subjective, cardiovascular and hormone effects and pharmacokinetics between mephedrone and alcohol in humans. [...]
2020 - 10.3389/fphar.2019.01588
Frontiers in Pharmacology, Vol. 10 (january 2020)  
3.
12 p, 639.1 KB Diario etnográfico de tres becarias en cuarentena : entre el aislamiento y la intimidad colectiva / Gerbaudo Suárez, Debora (Universidad Nacional de San Martín (Argentina). Instituto de Altos Estudios Sociales) ; Golé, Carla (Universidad de Buenos Aires. Instituto de Ciencias Antropológicas) ; Pérez, Camila (Universidad Nacional de San Martín (Argentina). Instituto de Altos Estudios Sociales)
Este escrito colectivo documenta nuestro primer mes de cuarentena obligatoria en el contexto de la pandemia de coronavirus en Buenos Aires. Como antropólogas y doctorandas nos enfrentamos a incertidumbres compartidas. [...]
This collective writing documents our first month of mandatory quarantine in the context of the coronavirus pandemic in Buenos Aires. As anthropologists and PhD students we face shared uncertainties. [...]

2020 - 10.5565/rev/periferia.756
Perifèria : revista de recerca i formació en antropologia, Vol. 25 Núm. 2 (2020) , p. 167-178 (Artículos)  
4.
4 p, 504.5 KB No tots els parcs urbans creen benestar relacional en els nens i nenes / Pérez del Pulgar, Carmen (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; Anguelovski, Isabelle (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; Connolly, James J. T. (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals)
Un estudi de dos parcs de Barcelona que han tingut diferents impactes en les habilitats socials dels nens mostra la importància de considerar les estructures socials en la planificació de nous parcs i espais urbans de joc. [...]
Un estudio de dos parques de Barcelona que han tenido diferentes impactos en las habilidades sociales de los niños muestra la importancia de considerar las estructuras sociales en la planificación de nuevos parques y espacios urbanos de juego. [...]
A study of two parks in Barcelona that have had very different impacts on children's social skills shows the importance of considering social structures in the planning of new parks and urban play spaces. [...]

2020
UAB divulga, Març 2020
3 documents
5.
50 p, 22.6 MB Pan-cancer analysis of whole genomes / Campbell, P.J. (Wellcome Sanger Institute) ; Getz, G. (Harvard Medical School) ; Korbel, J.O. (European Molecular Biology Laboratory (EMBL). Genome Biology Unit) ; Stuart, J.M. (Biomolecular Engineering Department. University of California Santa Cruz) ; Jennings, J.L. (International Cancer Genome Consortium (ICGC)/ICGC Accelerating Research in Genomic Oncology (ICGC-ARGO) Secretariat) ; Stein, L.D. (Department of Molecular Genetics. University of Toronto) ; Perry, M.D. (Genome Informatics Program. Ontario Institute for Cancer Research) ; Nahal-Bose, H.K. (Genome Informatics Program. Ontario Institute for Cancer Research) ; Ouellette, B.F.F. (Genome Informatics. Ontario Institute for Cancer Research) ; Li, C.H. (Department of Medical Biophysics. University of Toronto) ; Rheinbay, E. (Massachusetts General Hospital) ; Nielsen, G.P. (Massachusetts General Hospital) ; Sgroi, D.C. (Massachusetts General Hospital) ; Wu, C.L. (Massachusetts General Hospital) ; Faquin, W.C. (Massachusetts General Hospital) ; Deshpande, V. (Massachusetts General Hospital) ; Boutros, P.C. (University of California Los Angeles) ; Lazar, A.J. (Department of Pathology. Department of Genomic Medicine and Department of Translational Molecular Pathology. The University of Texas MD Anderson Cancer Center) ; Hoadley, K.A. (Lineberger Comprehensive Cancer Center. University of North Carolina at Chapel Hill) ; Louis, D.N. (Massachusetts General Hospital) ; Dursi, L.J. (The Hospital for Sick Children) ; Yung, C.K. (Genome Informatics Program. Ontario Institute for Cancer Research) ; Bailey, M.H. (The McDonnell Genome Institute. Washington University) ; Saksena, G. (Broad Institute of MIT and Harvard) ; Raine, K.M. (Wellcome Sanger Institute) ; Buchhalter, I. (Institute of Pharmacy and Molecular Biotechnology. and BioQuant. Heidelberg University) ; Kleinheinz, K. (Institute of Pharmacy and Molecular Biotechnology. and BioQuant. Heidelberg University) ; Schlesner, M. (Bioinformatics and Omics Data Analytics. German Cancer Research Center (DKFZ)) ; Zhang, J. (National Cancer Institute. National Institutes of Health) ; Wang, Wenyi (Department of Bioinformatics and Computational Biology. The University of Texas MD Anderson Cancer Center) ; Wheeler, D.A. (Human Genome Sequencing Center. Baylor College of Medicine) ; Ding, L. (Department of Genetics and Department of Medicine. Washington University in St Louis) ; Simpson, J.T. (Department of Computer Science. University of Toronto) ; O'Connor, B.D. (University of California Santa Cruz) ; Yakneen, S. (European Molecular Biology Laboratory (EMBL). Genome Biology Unit) ; Ellrott, K. (Computational Biology Program. Oregon Health & Science University) ; Miyoshi, N. (The Institute of Medical Science. The University of Tokyo) ; Butler, A.P. (Wellcome Sanger Institute) ; Royo, R. (Barcelona Supercomputing Center (BSC)) ; Shorser, S.I. (Computational Biology Program. Ontario Institute for Cancer Research) ; Vazquez, M. (Department of Clinical and Molecular Medicine. Faculty of Medicine and Health Sciences. Norwegian University of Science and Technology) ; Rausch, T. (European Molecular Biology Laboratory (EMBL). Genome Biology Unit) ; Tiao, G. (Broad Institute of MIT and Harvard) ; Waszak, S.M. (European Molecular Biology Laboratory (EMBL). Genome Biology Unit) ; Rodriguez-Martin, B. (The Biomedical Research Centre (CINBIO). Universidade de Vigo) ; Shringarpure, S. (Department of Genetics. Stanford University School of Medicine) ; Wu, D.Y. (Annai Systems) ; Demidov, G.M. (Universitat Pompeu Fabra (UPF)) ; Delaneau, O. (Swiss Institute of Bioinformatics. University of Geneva) ; Hayashi, S. (The Institute of Medical Science. The University of Tokyo) ; Imoto, S. (The Institute of Medical Science. The University of Tokyo) ; Habermann, N. (European Molecular Biology Laboratory (EMBL). Genome Biology Unit) ; Segre, A.V. (Department of Ophthalmology. Ocular Genomics Institute. Massachusetts Eye and Ear. Harvard Medical School) ; Garrison, E. (Wellcome Sanger Institute) ; Cafferkey, A. (European Molecular Biology Laboratory (EMBL). European Bioinformatics Institute (EMBL-EBI)) ; Alvarez, E.G. (The Biomedical Research Centre (CINBIO). Universidade de Vigo) ; Heredia-Genestar, J.M. (Department of Experimental and Health Sciences. Institute of Evolutionary Biology (UPF-CSIC). Universitat Pompeu Fabra (UPF)) ; Muyas, F. (Universitat Pompeu Fabra (UPF)) ; Drechsel, O. (Universitat Pompeu Fabra (UPF)) ; Bruzos, A.L. (The Biomedical Research Centre (CINBIO). Universidade de Vigo) ; Temes, J. (Department of Zoology. Genetics and Physical Anthropology. Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS). Universidade de Santiago de Compostela) ; Zamora, J. (Wellcome Sanger Institute) ; Baez-Ortega, A. (Department of Veterinary Medicine. Transmissible Cancer Group. University of Cambridge) ; Kim, H.L. (Department of Biochemistry. College of Medicine. Ewha Womans University) ; Mashl, R.J. (Division of Oncology. Washington University School of Medicine) ; Ye, K. (The First Affiliated Hospital. Xi'an Jiaotong University) ; DiBiase, A. (Independent Consultant) ; Huang, K.l. (Icahn School of Medicine at Mount Sinai) ; Letunic, I. (Biobyte Solutions) ; McLellan, M.D. (Department of Genetics and Department of Medicine. Washington University in St Louis) ; Newhouse, S.J. (European Molecular Biology Laboratory (EMBL). European Bioinformatics Institute (EMBL-EBI)) ; Shmaya, T. (Annai Systems) ; Kumar, S. (Program in Computational Biology and Bioinformatics. Yale University) ; Wedge, D.C. (Wellcome Sanger Institute) ; Wright, M.H. (Department of Genetics. Stanford University School of Medicine) ; Yellapantula, V.D. (The McDonnell Genome Institute at Washington University School of Medicine. and Department of Genetics and Department of Medicine. Siteman Cancer Center. Washington University in St Louis) ; Gerstein, M. (Department of Computer Science. Yale University) ; Khurana, E. (Institute for Computational Biomedicine. Weill Cornell Medicine) ; Marquès Bonet, Tomàs (Institut Català de Paleontologia Miquel Crusafont) ; Navarro, A. (Institució Catalana de Recerca i Estudis Avançats (ICREA)) ; Bustamante, C.D. (Department of Biomedical Data Science. Stanford University School of Medicine) ; Siebert, R. (Institute of Human Genetics. Ulm University and Ulm University Medical Center) ; Nakagawa, H. (RIKEN Center for Integrative Medical Sciences) ; Easton, D.F. (Department of Public Health and Primary Care. Centre for Cancer Genetic Epidemiology. University of Cambridge) ; Ossowski, S. (Universitat Pompeu Fabra (UPF)) ; Tubio, J.M.C. (The Biomedical Research Centre (CINBIO). Universidade de Vigo) ; De La Vega, F.M. (Department of Biomedical Data Science. Stanford University School of Medicine) ; Estivill, X. (Quantitative Genomics Laboratories (qGenomics)) ; Yuen, D. (Computational Biology Program. Ontario Institute for Cancer Research) ; Mihaiescu, G.L. (Genome Informatics Program. Ontario Institute for Cancer Research) ; Omberg, L. (Sage Bionetworks) ; Ferretti, V. (Department of Biochemistry and Molecular Medicine. University of Montreal. Montreal) ; Sabarinathan, R. (Research Program on Biomedical Informatics. Universitat Pompeu Fabra (UPF)) ; Pich, O. (Research Program on Biomedical Informatics. Universitat Pompeu Fabra (UPF)) ; Gonzalez-Perez, A. (Institut Hospital del Mar d'Investigacions Mèdiques (IMIM)) ; Taylor-Weiner, A. (Broad Institute of Harvard and MIT) ; Fittall, M.W. (The Francis Crick Institute) ; Demeulemeester, J. (University of Leuven) ; Tarabichi, M. (Wellcome Sanger Institute) ; Roberts, N.D. (Wellcome Sanger Institute) ; Van Loo, P. (University of Leuven) ; Cortés-Ciriano, I. (Ludwig Center at Harvard Medical School) ; Urban, L. (European Molecular Biology Laboratory (EMBL). Genome Biology Unit) ; Park, P. (Ludwig Center at Harvard Medical School) ; Zhu, B. (Division of Cancer Epidemiology and Genetics. National Cancer Institute. National Institutes of Health) ; Pitkänen, E. (European Molecular Biology Laboratory (EMBL). Genome Biology Unit) ; Li, Y. (Wellcome Sanger Institute) ; Saini, N. (Genome Integrity and Structural Biology Laboratory. National Institute of Environmental Health Sciences (NIEHS)) ; Klimczak, L.J. (Integrative Bioinformatics Support Group. National Institute of Environmental Health Sciences (NIEHS)) ; Weischenfeldt, J. (Finsen Laboratory and Biotech Research & Innovation Centre (BRIC). University of Copenhagen) ; Sidiropoulos, N. (Finsen Laboratory and Biotech Research & Innovation Centre (BRIC). University of Copenhagen) ; Alexandrov, L.B. (Wellcome Sanger Institute) ; Rabionet, R. (Department of Genetics. Microbiology and Statistics. University of Barcelona. IRSJD. IBUB) ; Escaramis, G. (Research Group on Statistics. Econometrics and Health (GRECS). UdG) ; Bosio, M. (Universitat Pompeu Fabra (UPF)) ; Holik, A.Z. (Centre for Genomic Regulation (CRG). The Barcelona Institute of Science and Technology (BIST)) ; Susak, H. (Universitat Pompeu Fabra (UPF)) ; Prasad, A. (Universitat Pompeu Fabra (UPF)) ; Erkek, S. (European Molecular Biology Laboratory (EMBL). Genome Biology Unit) ; Calabrese, C. (European Molecular Biology Laboratory (EMBL). Genome Biology Unit) ; Raeder, B. (European Molecular Biology Laboratory (EMBL). Genome Biology Unit) ; Harrington, E. (Oxford Nanopore Technologies) ; Mayes, S. (Applications Department. Oxford Nanopore Technologies) ; Turner, D. (Applications Department. Oxford Nanopore Technologies) ; Juul, S. (Oxford Nanopore Technologies) ; Roberts, S.A. (School of Molecular Biosciences and Center for Reproductive Biology. Washington State University) ; Song, L. (Division of Cancer Epidemiology and Genetics. National Cancer Institute. National Institutes of Health) ; Koster, R. (Laboratory of Translational Genomics. Division of Cancer Epidemiology and Genetics. National Cancer Institute. National Institutes of Health) ; Mirabello, L. (Division of Cancer Epidemiology and Genetics. National Cancer Institute. National Institutes of Health) ; Hua, X. (Division of Cancer Epidemiology and Genetics. National Cancer Institute. National Institutes of Health) ; Tanskanen, T.J. (Department of Medical and Clinical Genetics. Genome-Scale Biology Research Program. University of Helsinki) ; Tojo, M. (The Biomedical Research Centre (CINBIO). Universidade de Vigo) ; Chen, J. (Integrated Graduate Program in Physical and Engineering Biology. Yale University) ; Aaltonen, L.A. (Applied Tumor Genomics Research Program. Research Programs Unit. University of Helsinki) ; Rätsch, G. (Weill Cornell Medical College) ; Schwarz, R.F. (German Cancer Research Center (DKFZ)) ; Butte, A.J. (Bakar Computational Health Sciences Institute and Department of Pediatrics. University of California) ; Brazma, A. (European Molecular Biology Laboratory (EMBL). European Bioinformatics Institute (EMBL-EBI)) ; Chanock, S.J. (Division of Cancer Epidemiology and Genetics. National Cancer Institute. National Institutes of Health) ; Chatterjee, N. (Department of Oncology. The Johns Hopkins School of Medicine. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University) ; Stegle, O. (Division of Computational Genomics and Systems Genetics. German Cancer Research Center (DKFZ)) ; Harismendy, O. (Department of Medicine and Moores Cancer Center. Division of Biomedical Informatics. UC San Diego School of Medicine) ; Bova, G.S. (Faculty of Medicine and Health Technology. Tampere University and Tays Cancer Center. Tampere University Hospital) ; Gordenin, D.A. (Genome Integrity and Structural Biology Laboratory. National Institute of Environmental Health Sciences (NIEHS)) ; Haan, D. (Biomolecular Engineering Department. University of California Santa Cruz) ; Sieverling, L. (Faculty of Biosciences. Heidelberg University) ; Feuerbach, L. (Division of Applied Bioinformatics. German Cancer Research Center (DKFZ)) ; Chalmers, D. (Centre for Law and Genetics. University of Tasmania) ; Joly, Y. (Centre of Genomics and Policy. McGill University and Génome Québec Innovation Centre. Montreal) ; Knoppers, B. (Centre of Genomics and Policy. McGill University and Génome Québec Innovation Centre. Montreal) ; Molnár-Gábor, F. (Heidelberg Academy of Sciences and Humanities) ; Phillips, M. (Centre of Genomics and Policy. McGill University and Génome Québec Innovation Centre. Montreal) ; Thorogood, A. (Centre of Genomics and Policy. McGill University and Génome Québec Innovation Centre. Montreal) ; Townend, D. (CAPHRI Research School. Maastricht University) ; Goldman, M. (UC Santa Cruz Genomics Institute. University of California Santa Cruz) ; Fonseca, N.A. (CIBIO/InBIO. Research Center in Biodiversity and Genetic Resources. Universidade do Porto) ; Xiang, Q. (Ontario Institute for Cancer Research) ; Craft, B. (UC Santa Cruz Genomics Institute. University of California Santa Cruz) ; Piñeiro-Yáñez, E. (Bioinformatics Unit. Spanish National Cancer Research Centre (CNIO)) ; Muñoz, A. (European Molecular Biology Laboratory (EMBL). European Bioinformatics Institute (EMBL-EBI)) ; Petryszak, R. (European Molecular Biology Laboratory (EMBL). European Bioinformatics Institute (EMBL-EBI)) ; Füllgrabe, A. (European Molecular Biology Laboratory (EMBL). European Bioinformatics Institute (EMBL-EBI)) ; Al-Shahrour, F. (Bioinformatics Unit. Spanish National Cancer Research Centre (CNIO)) ; Keays, M. (European Molecular Biology Laboratory (EMBL). European Bioinformatics Institute (EMBL-EBI)) ; Haussler, D. (Howard Hughes Medical Institute. University of California Santa Cruz) ; Weinstein, J. (Department of Bioinformatics and Computational Biology and Department of Systems Biology. The University of Texas MD Anderson Cancer Center) ; Huber, W. (European Molecular Biology Laboratory (EMBL). Genome Biology Unit) ; Valencia, A. (Institució Catalana de Recerca i Estudis Avançats (ICREA)) ; Papatheodorou, I. (European Molecular Biology Laboratory (EMBL). European Bioinformatics Institute (EMBL-EBI)) ; Zhu, J. (UC Santa Cruz Genomics Institute. University of California Santa Cruz) ; Fan, Yu (Department of Bioinformatics and Computational Biology. The University of Texas MD Anderson Cancer Center) ; Torrents, D. (Institució Catalana de Recerca i Estudis Avançats (ICREA)) ; Bieg, M. (Heidelberg Center for Personalized Oncology (DKFZ-HIPO). German Cancer Research Center (DKFZ)) ; Chen, K. (Department of Bioinformatics and Computational Biology. University of Texas MD Anderson Cancer Center) ; Chong, Z. (Department of Genetics and Informatics Institute. University of Alabama at Birmingham) ; Cibulskis, K. (Broad Institute of MIT and Harvard) ; Eils, R. (New BIH Digital Health Center. Berlin Institute of Health (BIH) and Charité-Universitätsmedizin Berlin) ; Fulton, R.S. (Department of Genetics and Department of Medicine. Washington University in St Louis) ; Gelpi, J.L. (Department of Biochemistry and Molecular Biomedicine. University of Barcelona) ; Gonzalez, S. (European Molecular Biology Laboratory (EMBL). Genome Biology Unit) ; Gut, I.G. (CNAG-CRG. Centre for Genomic Regulation (CRG). Barcelona Institute of Science and Technology (BIST)) ; Hach, F. (Vancouver Prostate Centre) ; Heinold, M. (Institute of Pharmacy and Molecular Biotechnology. and BioQuant. Heidelberg University) ; Hu, T. (Division of Life Science and Applied Genomics Center. Hong Kong University of Science and Technology) ; Huang, V. (Computational Biology Program. Ontario Institute for Cancer Research) ; Hutter, B. (National Center for Tumor Diseases (NCT) Heidelberg) ; Jäger, N. (Division of Theoretical Bioinformatics. German Cancer Research Center (DKFZ)) ; Jung, J. (Genome Integration Data Center. Syntekabio) ; Kumar, Y. (Division of Life Science and Applied Genomics Center. Hong Kong University of Science and Technology) ; Lalansingh, C. (Computational Biology Program. Ontario Institute for Cancer Research) ; Leshchiner, I. (Broad Institute of MIT and Harvard) ; Livitz, D. (Broad Institute of MIT and Harvard) ; Ma, E.Z. (Division of Life Science and Applied Genomics Center. Hong Kong University of Science and Technology) ; Maruvka, Y.E. (Massachusetts General Hospital Center for Cancer Research) ; Milovanovic, A. (Barcelona Supercomputing Center (BSC)) ; Nielsen, M.M. (Department of Molecular Medicine (MOMA). Aarhus University Hospital) ; Paramasivam, N. (Heidelberg Center for Personalized Oncology (DKFZ-HIPO). German Cancer Research Center (DKFZ)) ; Pedersen, J.S. (Bioinformatics Research Centre (BiRC). Aarhus University) ; Puiggròs, M. (Barcelona Supercomputing Center (BSC)) ; Sahinalp, S.C. (Simon Fraser University) ; Sarrafi, I. (Simon Fraser University) ; Stewart, C. (Broad Institute of MIT and Harvard) ; Stobbe, M.D. (CNAG-CRG. Centre for Genomic Regulation (CRG). Barcelona Institute of Science and Technology (BIST)) ; Wala, J.A. (Dana-Farber Cancer Institute) ; Wang, J. (BGI-Shenzhen) ; Wendl, M. (Department of Mathematics. Washington University in St Louis) ; Werner, J. (Department of Biological Oceanography. Leibniz Institute of Baltic Sea Research) ; Wu, Z. (Division of Life Science and Applied Genomics Center. Hong Kong University of Science and Technology) ; Xue, H. (Division of Life Science and Applied Genomics Center. Hong Kong University of Science and Technology) ; Yamaguchi, T.N. (Computational Biology Program. Ontario Institute for Cancer Research) ; Yellapantula, V. (The McDonnell Genome Institute at Washington University School of Medicine. and Department of Genetics and Department of Medicine. Siteman Cancer Center. Washington University in St Louis) ; Davis-Dusenbery, B.N. (Seven Bridges Genomics) ; Grossman, R.L. (University of Chicago) ; Kim, Y. (Samsung Genome Institute) ; Heinold, M.C. (Institute of Pharmacy and Molecular Biotechnology. and BioQuant. Heidelberg University) ; Hinton, J. (Wellcome Sanger Institute) ; Jones, D.R. (Wellcome Sanger Institute) ; Menzies, A. (Wellcome Sanger Institute) ; Stebbings, L. (Wellcome Sanger Institute) ; Hess, J.M. (Massachusetts General Hospital Center for Cancer Research) ; Rosenberg, M. (Massachusetts General Hospital) ; Dunford, A.J. (Broad Institute of MIT and Harvard) ; Gupta, M. (Broad Institute of MIT and Harvard) ; Imielinski, M. (Weill Cornell Medicine) ; Meyerson, M. (Dana-Farber Cancer Institute) ; Beroukhim, R. (Department of Medical Oncology. Dana-Farber Cancer Institute) ; Reimand, J. (Department of Medical Biophysics. University of Toronto) ; Dhingra, P. (Institute for Computational Biomedicine. Weill Cornell Medicine) ; Favero, F. (Rigshospitalet) ; Dentro, S. (Wellcome Sanger Institute) ; Wintersinger, J. (Vector Institute) ; Rudneva, V. (European Molecular Biology Laboratory (EMBL). Genome Biology Unit) ; Park, J.W. (Center for Liver Cancer. Research Institute and Hospital. National Cancer Center) ; Hong, E.P. (Department of Medical Genetics. College of Medicine. Hallym University) ; Heo, S.G. (Department of Medical Genetics. College of Medicine. Hallym University) ; Kahles, A. (University Hospital Zurich) ; Lehmann, K.V. (University Hospital Zurich) ; Soulette, C.M. (University of California Santa Cruz) ; Shiraishi, Y. (The Institute of Medical Science. The University of Tokyo) ; Liu, F. (School of Life Sciences. Peking University) ; He, Y. (Peking University) ; Demircioğlu, D. (School of Computing. National University of Singapore) ; Davidson, N.R. (Department of Biology. ETH Zurich) ; Greger, L. (European Molecular Biology Laboratory (EMBL). European Bioinformatics Institute (EMBL-EBI)) ; Li, S. (China National GeneBank-Shenzhen) ; Liu, D. (China National GeneBank-Shenzhen) ; Stark, S.G. (Korea University) ; Zhang, F. (Peking University) ; Amin, S.B. (The Jackson Laboratory for Genomic Medicine) ; Bailey, P. (Wolfson Wohl Cancer Research Centre. Institute of Cancer Sciences. University of Glasgow) ; Chateigner, A. (Genome Informatics Program. Ontario Institute for Cancer Research) ; Frenkel-Morgenstern, M. (The Azrieli Faculty of Medicine. Bar-Ilan University) ; Hou, Y. (China National GeneBank-Shenzhen) ; Huska, M.R. (Berlin Institute for Medical Systems Biology. Max Delbrück Center for Molecular Medicine) ; Kilpinen, H. (University College London) ; Lamaze, F.C. (Computational Biology Program. Ontario Institute for Cancer Research) ; Li, C. (China National GeneBank-Shenzhen) ; Li, X. (China National GeneBank-Shenzhen) ; Liu, X. (China National GeneBank-Shenzhen) ; Marin, M.G. (University of California Santa Cruz) ; Markowski, J. (Berlin Institute for Medical Systems Biology. Max Delbrück Center for Molecular Medicine) ; Nandi, T. (Genome Institute of Singapore) ; Ojesina, A.I. (O'Neal Comprehensive Cancer Center. University of Alabama at Birmingham) ; Pan-Hammarström, Q. (Department of Biosciences and Nutrition. Karolinska Institutet) ; Park, P.J. (Ludwig Center at Harvard Medical School) ; Pedamallu, C.S. (Department of Medical Oncology. Dana-Farber Cancer Institute) ; Su, H. (China National GeneBank-Shenzhen) ; Tan, P. (SingHealth. Duke-NUS Institute of Precision Medicine. National Heart Centre Singapore) ; Teh, B.T. (Laboratory of Cancer Epigenome. Division of Medical Science. National Cancer Centre Singapore) ; Wang, J. (BGI-Shenzhen) ; Xiong, H. (China National GeneBank-Shenzhen) ; Ye, C. (China National GeneBank-Shenzhen) ; Yung, C. (Genome Informatics Program. Ontario Institute for Cancer Research) ; Zhang, X. (The University of Texas Health Science Center at Houston) ; Zheng, L. (Peking University) ; Zhu, S. (China National GeneBank-Shenzhen) ; Awadalla, P. (Department of Molecular Genetics. University of Toronto) ; Creighton, C.J. (Department of Medicine. Baylor College of Medicine) ; Wu, K. (China National GeneBank-Shenzhen) ; Yang, H. (BGI-Shenzhen) ; Göke, J. (National Cancer Centre Singapore) ; Zhang, Z. (BIOPIC. ICG and College of Life Sciences. Peking University) ; Brooks, A.N. (Dana-Farber Cancer Institute) ; Fittall, M.W. (The Francis Crick Institute) ; Martincorena, I. (Wellcome Sanger Institute) ; Rubio-Perez, C. (Vall d'Hebron Institute of Oncology (VHIO)) ; Juul, M. (Department of Molecular Medicine (MOMA). Aarhus University Hospital) ; Schumacher, S. (Department of Cancer Biology. Dana-Farber Cancer Institute) ; Shapira, O. (Dana-Farber Cancer Institute) ; Tamborero, D. (Research Program on Biomedical Informatics. Universitat Pompeu Fabra (UPF)) ; Mularoni, L. (Research Program on Biomedical Informatics. Universitat Pompeu Fabra (UPF)) ; Hornshøj, H. (Department of Molecular Medicine (MOMA). Aarhus University Hospital) ; Deu-Pons, J. (Institute for Research in Biomedicine (IRB Barcelona). The Barcelona Institute of Science and Technology (BIST)) ; Muiños, F. (Research Program on Biomedical Informatics. Universitat Pompeu Fabra (UPF)) ; Bertl, J. (Department of Mathematics. Aarhus University) ; Guo, Q. (Bioinformatics Research Centre (BiRC). Aarhus University) ; Gonzalez-Perez, A. (Institut Hospital del Mar d'Investigacions Mèdiques (IMIM)) ; Xiang, Q. (Ontario Institute for Cancer Research) ; Bazant, W. (European Molecular Biology Laboratory (EMBL). European Bioinformatics Institute (EMBL-EBI)) ; Barrera, E. (European Molecular Biology Laboratory (EMBL). European Bioinformatics Institute (EMBL-EBI)) ; Al-Sedairy, S.T. (King Faisal Specialist Hospital and Research Centre) ; Aretz, A. (DLR Project Management Agency) ; Bell, C. (Genome Canada) ; Betancourt, M. (Instituto Carlos Slim de la Salud) ; Buchholz, C. (Federal Ministry of Education and Research) ; Calvo, F. (Institut Gustave Roussy) ; Chomienne, C. (Institut National du Cancer (INCA)) ; Dunn, M. (The Wellcome Trust) ; Edmonds, S. (Prostate Cancer Canada) ; Green, E. (National Human Genome Research Institute. National Institutes of Health) ; Gupta, S. (Department of Biotechnology. Ministry of Science & Technology. Government of India. New Delhi) ; Hutter, C.M. (National Human Genome Research Institute. National Institutes of Health) ; Jegalian, K. (Science Writer) ; Jones, N. (Cancer Research UK) ; Lu, Y. (Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education). Peking University Cancer Hospital & Institute) ; Nakagama, H. (National Cancer Center) ; Nettekoven, G. (German Cancer Aid) ; Planko, L. (German Cancer Aid) ; Scott, D. (Cancer Research UK) ; Shibata, T. (Laboratory of Molecular Medicine. Human Genome Center. The Institute of Medical Science. The University of Tokyo) ; Shimizu, K. (Japan Agency for Medical Research and Development) ; Stratton, M.R. (Wellcome Sanger Institute) ; Yugawa, T. (Japan Agency for Medical Research and Development) ; Tortora, G. (University of Verona) ; VijayRaghavan, K. (Department of Biotechnology. Ministry of Science & Technology. Government of India. New Delhi) ; Zenklusen, J.C. (National Cancer Institute. National Institutes of Health) ; Townend, D. (CAPHRI Research School. Maastricht University) ; Knoppers, B.M. (Centre of Genomics and Policy. McGill University and Génome Québec Innovation Centre. Montreal) ; Aminou, B. (Genome Informatics Program. Ontario Institute for Cancer Research) ; Bartolome, Javier (Barcelona Supercomputing Center (BSC)) ; Boroevich, K.A. (Laboratory for Medical Science Mathematics. RIKEN Center for Integrative Medical Sciences) ; Boyce, R. (European Molecular Biology Laboratory (EMBL). European Bioinformatics Institute (EMBL-EBI)) ; Buchanan, A. (Computational Biology Program. Oregon Health & Science University) ; Byrne, N.J. (Genome Informatics Program. Ontario Institute for Cancer Research) ; Chen, Z. (University of California San Diego) ; Cho, S. (PDXen Biosystems) ; Choi, W. (Electronics and Telecommunications Research Institute) ; Clapham, P. (Wellcome Sanger Institute) ; Dow, M.T. (University of California San Diego) ; Dursi, L.J. (The Hospital for Sick Children) ; Eils, J. (New BIH Digital Health Center. Berlin Institute of Health (BIH) and Charité-Universitätsmedizin Berlin) ; Farcas, C. (University of California San Diego) ; Fayzullaev, N. (Genome Informatics Program. Ontario Institute for Cancer Research) ; Flicek, P. (European Molecular Biology Laboratory (EMBL). European Bioinformatics Institute (EMBL-EBI)) ; Heath, A.P. (Children's Hospital of Philadelphia) ; Hofmann, O. (University of Melbourne Centre for Cancer Research) ; Hong, J.H. (Syntekabio) ; Hudson, T.J. (Genomics Research Program. Ontario Institute for Cancer Research) ; Hübschmann, D. (Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM)) ; Ivkovic, S. (Seven Bridges) ; Jeon, S.H. (Electronics and Telecommunications Research Institute) ; Jiao, W. (Computational Biology Program. Ontario Institute for Cancer Research) ; Kabbe, R. (Division of Theoretical Bioinformatics. German Cancer Research Center (DKFZ)) ; Kahles, A. (University Hospital Zurich) ; Kerssemakers, J.N.A. (Division of Theoretical Bioinformatics. German Cancer Research Center (DKFZ)) ; Kim, H. (Electronics and Telecommunications Research Institute) ; Kim, J. (Health Sciences Department of Biomedical Informatics. University of California San Diego) ; Koscher, M. (Functional and Structural Genomics. German Cancer Research Center (DKFZ)) ; Koures, A. (University of California San Diego) ; Kovacevic, M. (Seven Bridges) ; Lawerenz, C. (New BIH Digital Health Center. Berlin Institute of Health (BIH) and Charité-Universitätsmedizin Berlin) ; Liu, J. (Leidos Biomedical Research) ; Mijalkovic, S. (Seven Bridges) ; Mijalkovic-Lazic, A.M. (Seven Bridges) ; Miyano, S. (The Institute of Medical Science. The University of Tokyo) ; Nastic, M. (Seven Bridges) ; Nicholson, J. (Wellcome Sanger Institute) ; Ocana, D. (European Molecular Biology Laboratory (EMBL). European Bioinformatics Institute (EMBL-EBI)) ; Ohi, K. (The Institute of Medical Science. The University of Tokyo) ; Ohno-Machado, L. (University of California San Diego) ; Pihl, T.D. (CSRA Incorporated) ; Prinz, M. (Division of Theoretical Bioinformatics. German Cancer Research Center (DKFZ)) ; Radovic, P. (Seven Bridges) ; Short, C. (European Molecular Biology Laboratory (EMBL). European Bioinformatics Institute (EMBL-EBI)) ; Sofia, H.J. (National Human Genome Research Institute. National Institutes of Health) ; Spring, J. (University of Chicago) ; Struck, A.J. (Computational Biology Program. Oregon Health & Science University) ; Tijanic, N. (Seven Bridges) ; Vicente, D. (Barcelona Supercomputing Center (BSC)) ; Wang, Z. (National Cancer Institute. National Institutes of Health) ; Williams, A. (University of California San Diego) ; Woo, Y. (Electronics and Telecommunications Research Institute) ; Wright, A.J. (Computational Biology Program. Ontario Institute for Cancer Research) ; Yang, L. (Ben May Department for Cancer Research. Department of Human Genetics. The University of Chicago) ; Hamilton, M.P. (Department of Internal Medicine. Stanford University) ; Johnson, T.A. (Laboratory for Medical Science Mathematics. RIKEN Center for Integrative Medical Sciences) ; Kahraman, A. (Institute of Molecular Life Sciences. University of Zurich) ; Kellis, M. (MIT Computer Science and Artificial Intelligence Laboratory. Massachusetts Institute of Technology) ; Polak, P. (Harvard Medical School) ; Sallari, R. (Broad Institute of MIT and Harvard) ; Sinnott-Armstrong, N. (Department of Genetics. Stanford University School of Medicine) ; von Mering, C. (Institute of Molecular Life Sciences and Swiss Institute of Bioinformatics. University of Zurich) ; Beltran, S. (CNAG-CRG. Centre for Genomic Regulation (CRG). Barcelona Institute of Science and Technology (BIST)) ; Gerhard, D.S. (Office of Cancer Genomics. National Cancer Institute. National Institutes of Health) ; Gut, M. (CNAG-CRG. Centre for Genomic Regulation (CRG). Barcelona Institute of Science and Technology (BIST)) ; Trotta, J.R. (CNAG-CRG. Centre for Genomic Regulation (CRG). Barcelona Institute of Science and Technology (BIST)) ; Whalley, J.P. (CNAG-CRG. Centre for Genomic Regulation (CRG). Barcelona Institute of Science and Technology (BIST)) ; Niu, B. (Computer Network Information Center. Chinese Academy of Sciences) ; Espiritu, S.M.G. (Computational Biology Program. Ontario Institute for Cancer Research) ; Gao, S. (BGI-Shenzhen) ; Huang, Y. (Geneplus-Shenzhen) ; Lalansingh, C.M. (Computational Biology Program. Ontario Institute for Cancer Research) ; Teague, J.W. (Wellcome Sanger Institute) ; Wendl, M.C. (Department of Mathematics. Washington University in St Louis) ; Abascal, F. (Wellcome Sanger Institute) ; Bader, G.D. (Department of Molecular Genetics. University of Toronto) ; Bandopadhayay, P. (Department of Pediatrics. Harvard Medical School) ; Barenboim, J. (Computational Biology Program. Ontario Institute for Cancer Research) ; Brunak, S. (University of Copenhagen) ; Carlevaro-Fita, J. (Graduate School for Cellular and Biomedical Sciences. University of Bern) ; Chakravarty, D. (Department of Urology. Icahn School of Medicine at Mount Sinai) ; Chan, C.W.Y. (Faculty of Biosciences. Heidelberg University) ; Choi, J.K. (Korea Advanced Institute of Science and Technology) ; Diamanti, K. (Science for Life Laboratory. Department of Cell and Molecular Biology. Uppsala University) ; Fink, J.L. (Queensland Centre for Medical Genomics. Institute for Molecular Bioscience. The University of Queensland) ; Frigola, J. (Institute for Research in Biomedicine (IRB Barcelona). The Barcelona Institute of Science and Technology (BIST)) ; Gambacorti-Passerini, C. (University of Milano Bicocca) ; Garsed, D.W. (Sir Peter MacCallum Department of Oncology. Peter MacCallum Cancer Centre. University of Melbourne) ; Haradhvala, N.J. (Massachusetts General Hospital) ; Harmanci, A.O. (Center for Precision Health. School of Biomedical Informatics. The University of Texas Health Science Center) ; Helmy, M. (The Donnelly Centre. University of Toronto) ; Herrmann, C. (Health Data Science Unit. University Clinics) ; Hobolth, A. (Department of Mathematics. Aarhus University) ; Hodzic, E. (Simon Fraser University) ; Hong, C. (Faculty of Biosciences. Heidelberg University) ; Isaev, K. (Department of Medical Biophysics. University of Toronto) ; Izarzugaza, J.M.G. (Technical University of Denmark) ; Johnson, R. (Department for Biomedical Research. University of Bern) ; Juul, R.I. (Department of Molecular Medicine (MOMA). Aarhus University Hospital) ; Kim, J. (Health Sciences Department of Biomedical Informatics. University of California San Diego) ; Kim, J.K. (Research Core Center. National Cancer Centre Korea) ; Jan Komorowski, None (Institute of Computer Science. Polish Academy of Sciences) ; Lanzós, A. (Department for Biomedical Research. University of Bern) ; Larsson, E. (Computational Biology Center. Memorial Sloan Kettering Cancer Center) ; Lee, D. (Canada's Michael Smith Genome Sciences Center. BC Cancer Agency) ; Li, S. (China National GeneBank-Shenzhen) ; Li, X. (China National GeneBank-Shenzhen) ; Lin, Z. (Harvard University) ; Liu, E.M. (Memorial Sloan Kettering Cancer Center) ; Lochovsky, L. (The Jackson Laboratory for Genomic Medicine) ; Lou, S. (Program in Computational Biology and Bioinformatics. Yale University) ; Madsen, T. (Department of Molecular Medicine (MOMA). Aarhus University Hospital) ; Marchal, K. (Department of Plant Biotechnology and Bioinformatics. Ghent University) ; Martinez-Fundichely, A. (Institute for Computational Biomedicine. Weill Cornell Medicine) ; McGillivray, P.D. (Department of Molecular Biophysics and Biochemistry. Yale University) ; Meyerson, W. (Yale School of Medicine. Yale University) ; Paczkowska, M. (Computational Biology Program. Ontario Institute for Cancer Research) ; Park, K. (Cheonan Industry-Academic Collaboration Foundation. Sangmyung University) ; Pons, T. (Spanish National Cancer Research Centre) ; Pulido-Tamayo, S. (Department of Plant Biotechnology and Bioinformatics. Ghent University) ; Reyes-Salazar, I. (Institute for Research in Biomedicine (IRB Barcelona)) ; Reyna, M.A. (Department of Computer Science. Princeton University) ; Rubin, M.A. (Pathology and Laboratory. Weill Cornell Medical College) ; Salichos, L. (Program in Computational Biology and Bioinformatics. Yale University) ; Sander, C. (Department of Cell Biology. Harvard Medical School) ; Schumacher, S.E. (Department of Cancer Biology. Dana-Farber Cancer Institute) ; Shackleton, M. (Sir Peter MacCallum Department of Oncology. Peter MacCallum Cancer Centre. University of Melbourne) ; Shen, C. (cBio Center. Dana-Farber Cancer Institute) ; Shrestha, R. (Vancouver Prostate Centre) ; Shuai, S. (Department of Molecular Genetics. University of Toronto) ; Tsunoda, T. (Laboratory for Medical Science Mathematics. Department of Biological Sciences. Graduate School of Science. The University of Tokyo) ; Umer, H.M. (Science for Life Laboratory. Department of Oncology-Pathology. Karolinska Institutet) ; Uusküla-Reimand, L. (Genetics & Genome Biology Program. SickKids Research Institute. The Hospital for Sick Children) ; Verbeke, L.P.C. (Department of Information Technology. Ghent University. Interuniversitair Micro-Electronica Centrum (IMEC)) ; Wadelius, C. (Science for Life Laboratory. Department of Immunology. Genetics and Pathology. Uppsala University) ; Wadi, L. (Computational Biology Program. Ontario Institute for Cancer Research) ; Warrell, J. (Program in Computational Biology and Bioinformatics. Yale University) ; Wu, G. (Oregon Health & Sciences University) ; Yu, J. (Department of Medicine and Therapeutics. The Chinese University of Hong Kong) ; Zhang, J. (National Cancer Institute. National Institutes of Health) ; Zhang, X. (The University of Texas Health Science Center at Houston) ; Zhang, Y. (The Ohio State University Comprehensive Cancer Center (OSUCCC - James)) ; Zhao, Z. (The University of Texas School of Biomedical Informatics (SBMI) at Houston) ; Zou, L. (Department of Biochemistry and Molecular Genetics. Feinberg School of Medicine. Northwestern University) ; Lawrence, M.S. (Laboratory for Medical Science Mathematics. RIKEN Center for Integrative Medical Sciences) ; Raphael, B.J. (Department of Computer Science. Princeton University) ; Bailey, P.J. (Wolfson Wohl Cancer Research Centre. Institute of Cancer Sciences. University of Glasgow) ; Craft, D. (Physics Division. Optimization and Systems Biology Lab. Massachusetts General Hospital) ; Goldman, M.J. (UC Santa Cruz Genomics Institute. University of California Santa Cruz) ; Aburatani, H. (Genome Science Division. Research Center for Advanced Science and Technology. The University of Tokyo) ; Binder, H. (Interdisciplinary Center for Bioinformatics. University of Leipzig) ; Dinh, H.Q. (Center for Bioinformatics and Functional Genomics. Cedars-Sinai Medical Center) ; Heath, S.C. (CNAG-CRG. Centre for Genomic Regulation (CRG). Barcelona Institute of Science and Technology (BIST)) ; Hoffmann, S. (Transcriptome Bioinformatics. LIFE Research Center for Civilization Diseases. University of Leipzig) ; Imbusch, C.D. (Division of Applied Bioinformatics. German Cancer Research Center (DKFZ)) ; Kretzmer, H. (Transcriptome Bioinformatics. LIFE Research Center for Civilization Diseases. University of Leipzig) ; Laird, P.W. (Center for Epigenetics. Van Andel Research Institute) ; Martin-Subero, J.I. (Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)) ; Nagae, G. (Research Center for Advanced Science and Technology. The University of Tokyo) ; Shen, H. (Van Andel Research Institute) ; Wang, Q. (Functional and Structural Genomics. German Cancer Research Center (DKFZ)) ; Weichenhan, D. (Cancer Epigenomics. German Cancer Research Center (DKFZ)) ; Zhou, W. (Van Andel Research Institute) ; Berman, B.P. (The Hebrew University Faculty of Medicine) ; Brors, B. (German Cancer Consortium (DKTK). German Cancer Research Center (DKFZ)) ; Plass, C. (Cancer Epigenomics. German Cancer Research Center (DKFZ)) ; Akdemir, K.C. (Department of Bioinformatics and Computational Biology. University of Texas MD Anderson Cancer Center) ; Bowtell, D.D.L. (Sir Peter MacCallum Department of Oncology. Peter MacCallum Cancer Centre. University of Melbourne) ; Burns, K.H. (McKusick-Nathans Institute of Genetic Medicine. Sidney Kimmel Comprehensive Cancer Center. Johns Hopkins University School of Medicine) ; Busanovich, J. (Foundation Medicine) ; Chan, K. (Department of Biochemistry. Microbiology and Immunology. Faculty of Medicine. University of Ottawa) ; Dueso-Barroso, A. (Barcelona Supercomputing Center (BSC)) ; Edwards, P.A. (University of Cambridge) ; Etemadmoghadam, D. (Sir Peter MacCallum Department of Oncology. Peter MacCallum Cancer Centre. University of Melbourne) ; Haber, J.E. (Brandeis University) ; Jones, D.T.W. (Pediatric Glioma Research Group. German Cancer Research Center (DKFZ)) ; Ju, Y.S. (Wellcome Sanger Institute) ; Kazanov, M.D. (Skolkovo Institute of Science and Technology) ; Koh, Y. (Department of Internal Medicine. Seoul National University Hospital) ; Kumar, K. (Broad Institute of MIT and Harvard) ; Lee, E.A. (Division of Genetics and Genomics. Boston Children's Hospital. Harvard Medical School) ; Lee, J.J.K. (Ludwig Center at Harvard Medical School) ; Lynch, A.G. (School of Medicine/School of Mathematics and Statistics. University of St Andrews) ; Macintyre, G. (Cancer Research UK Cambridge Institute. University of Cambridge) ; Markowetz, F. (University of Cambridge) ; Navarro, F.C.P. (Department of Molecular Biophysics and Biochemistry. Yale University) ; Pearson, J.V. (Institute for Molecular Bioscience. University of Queensland) ; Rippe, K. (German Cancer Research Center (DKFZ)) ; Scully, R. (Cancer Research Institute. Beth Israel Deaconess Medical Center) ; Villasante, I. (Barcelona Supercomputing Center (BSC)) ; Waddell, N. (Institute for Molecular Bioscience. University of Queensland) ; Yang, L. (Ben May Department for Cancer Research. Department of Human Genetics. The University of Chicago) ; Yao, X. (Tri-Institutional PhD Program in Computational Biology and Medicine. Weill Cornell Medicine) ; Yoon, S.S. (Department of Internal Medicine. Seoul National University Hospital) ; Zhang, C.Z. (Dana-Farber Cancer Institute) ; Bergstrom, E.N. (Department of Bioengineering. and Department of Cellular and Molecular Medicine. Moores Cancer Center. University of California. San Diego) ; Boot, A. (Centre for Computational Biology. Duke-NUS Medical School) ; Covington, K. (Human Genome Sequencing Center. Baylor College of Medicine) ; Fujimoto, A. (RIKEN Center for Integrative Medical Sciences) ; Huang, M.N. (Centre for Computational Biology. Duke-NUS Medical School) ; Islam, S.M.A. (Department of Bioengineering and Department of Cellular and Molecular Medicine. Moores Cancer Center. University of California San Diego) ; McPherson, J.R. (Centre for Computational Biology. Duke-NUS Medical School) ; Morganella, S. (Wellcome Sanger Institute) ; Mustonen, V. (Organismal and Evolutionary Biology Research Programme. University of Helsinki) ; Ng, A.W.T. (Programme in Cancer & Stem Cell Biology. Centre for Computational Biology. Duke-NUS Medical School) ; Prokopec, S.D. (Computational Biology Program. Ontario Institute for Cancer Research) ; Vázquez-García, I. (Wellcome Sanger Institute) ; Wu, Y. (Centre for Computational Biology. Duke-NUS Medical School) ; Yousif, F. (Computational Biology Program. Ontario Institute for Cancer Research) ; Yu, W. (Duke-NUS Medical School) ; Rozen, S.G. (Centre for Computational Biology. Duke-NUS Medical School) ; Rudneva, V.A. (European Molecular Biology Laboratory (EMBL). Genome Biology Unit) ; Shringarpure, S.S. (Department of Genetics. Stanford University School of Medicine) ; Turner, D.J. (Applications Department. Oxford Nanopore Technologies) ; Xia, T. (School of Electronic Information and Communications. Huazhong University of Science and Technology) ; Atwal, G. (Vector Institute) ; Chang, D.K. (The Kinghorn Cancer Centre. Cancer Division. Garvan Institute of Medical Research. University of New South Wales) ; Cooke, S.L. (Wolfson Wohl Cancer Research Centre. Institute of Cancer Sciences. University of Glasgow) ; Faltas, B.M. (Weill Cornell Medical College) ; Haider, S. (Computational Biology Program. Ontario Institute for Cancer Research) ; Kaiser, V.B. (MRC Human Genetics Unit. MRC IGMM. University of Edinburgh) ; Karlić, R. (Bioinformatics Group. Division of Molecular Biology. Department of Biology. Faculty of Science. University of Zagreb) ; Kato, M. (Department of Bioinformatics. Division of Cancer Genomics. National Cancer Center Research Institute. National Cancer Center) ; Kübler, K. (Massachusetts General Hospital) ; Margolin, A. (Computational Biology Program. Oregon Health & Science University) ; Martin, S. (Wellcome Sanger Institute) ; Nik-Zainal, S. (Wellcome Sanger Institute) ; P'ng, C. (Computational Biology Program. Ontario Institute for Cancer Research) ; Semple, C.A. (MRC Human Genetics Unit. MRC IGMM. University of Edinburgh) ; Smith, J. (Computational Biology Program. Oregon Health & Science University) ; Sun, R.X. (Computational Biology Program. Ontario Institute for Cancer Research) ; Thai, K. (Genome Informatics Program. Ontario Institute for Cancer Research) ; Wright, D.W. (Wolfson Wohl Cancer Research Centre. Institute of Cancer Sciences. University of Glasgow) ; Yuan, K. (School of Computing Science. University of Glasgow) ; Biankin, A.V. (West of Scotland Pancreatic Unit. Glasgow Royal Infirmary) ; Garraway, L. (Dana-Farber Cancer Institute) ; Grimmond, S.M. (University of Melbourne Centre for Cancer Research) ; Adams, D.J. (Wellcome Sanger Institute) ; Anur, P. (Molecular and Medical Genetics. Oregon Health & Science University) ; Cao, S. (Department of Bioinformatics and Computational Biology. The University of Texas MD Anderson Cancer Center) ; Christie, E.L. (Sir Peter MacCallum Department of Oncology. Peter MacCallum Cancer Centre. University of Melbourne) ; Cmero, M. (Walter + Eliza Hall Institute) ; Cun, Y. (University of Cologne) ; Dawson, K.J. (Wellcome Sanger Institute) ; Dentro, S.C. (Wellcome Sanger Institute) ; Deshwar, A.G. (The Edward S. Rogers Sr Department of Electrical and Computer Engineering. University of Toronto) ; Donmez, N. (Simon Fraser University) ; Drews, R.M. (Cancer Research UK Cambridge Institute. University of Cambridge) ; Gerstung, M. (European Molecular Biology Laboratory (EMBL). Genome Biology Unit) ; Ha, G. (Broad Institute of MIT and Harvard) ; Haase, K. (The Francis Crick Institute) ; Jerman, L. (University of Ljubljana) ; Ji, Y. (Research Institute. NorthShore University HealthSystem) ; Jolly, C. (The Francis Crick Institute) ; Lee, J. (Department of Statistics. University of California Santa Cruz) ; Lee-Six, H. (Wellcome Sanger Institute) ; Malikic, S. (Simon Fraser University) ; Mitchell, T.J. (Wellcome Sanger Institute) ; Morris, Q.D. (University of Toronto) ; Oesper, L. (Department of Computer Science. Carleton College) ; Peifer, M. (University of Cologne) ; Peto, M. (Molecular and Medical Genetics. Oregon Health & Science University) ; Rosebrock, D. (Broad Institute of MIT and Harvard) ; Rubanova, Y. (Vector Institute) ; Salcedo, A. (Computational Biology Program. Ontario Institute for Cancer Research) ; Sengupta, S. (Center for Psychiatric Genetics. NorthShore University HealthSystem) ; Shi, R. (University of Toronto) ; Shin, S.J. (Korea University) ; Spiro, O. (Broad Institute of MIT and Harvard) ; Vembu, S. (Argmix Consulting) ; Wintersinger, J.A. (Vector Institute) ; Yang, T.P. (University of Cologne) ; Yu, K. (Department of Biostatistics. The University of Texas MD Anderson Cancer Center) ; Zhu, H. (The University of Texas MD Anderson Cancer Center) ; Spellman, P.T. (Molecular and Medical Genetics. Knight Cancer Institute. Oregon Health & Science University) ; Weinstein, J.N. (Department of Bioinformatics and Computational Biology and Department of Systems Biology. The University of Texas MD Anderson Cancer Center) ; Chen, Y. (Department of Bioinformatics and Computational Biology. The University of Texas MD Anderson Cancer Center) ; Fujita, M. (RIKEN Center for Integrative Medical Sciences) ; Han, L. (The University of Texas Health Science Center at Houston) ; Hasegawa, T. (The Institute of Medical Science. The University of Tokyo) ; Komura, M. (The Institute of Medical Science. The University of Tokyo) ; Li, J. (Department of Bioinformatics and Computational Biology. The University of Texas MD Anderson Cancer Center) ; Mizuno, S. (Department of Health Sciences. Faculty of Medical Sciences. Kyushu University) ; Shimizu, E. (The Institute of Medical Science. The University of Tokyo) ; Wang, Y. (Baylor College of Medicine) ; Xu, Y. (Department of Applied Mathematics and Statistics. Johns Hopkins University) ; Yamaguchi, R. (The Institute of Medical Science. The University of Tokyo) ; Yang, F. (University of Toronto) ; Yang, Y. (The University of Texas Health Science Center at Houston) ; Yoon, C.J. (Korea Advanced Institute of Science and Technology) ; Yuan, Y. (Department of Bioinformatics and Computational Biology. The University of Texas MD Anderson Cancer Center) ; Liang, H. (Department of Bioinformatics and Computational Biology. The University of Texas MD Anderson Cancer Center) ; Alawi, M. (University Medical Center Hamburg-Eppendorf. Bioinformatics Core) ; Borozan, I. (Computational Biology Program. Ontario Institute for Cancer Research) ; Brewer, D.S. (Norwich Medical School. University of East Anglia) ; Cooper, C.S. (University of East Anglia) ; Desai, N. (Genome Informatics Program. Ontario Institute for Cancer Research) ; Grundhoff, A. (German Center for Infection Research (DZIF). Partner Site Hamburg-Borstel-Lübeck-Riems) ; Iskar, M. (Division of Molecular Genetics. German Cancer Research Center (DKFZ)) ; Su, X. (Department of Pathology. The University of Texas MD Anderson Cancer Center) ; Zapatka, M. (Division of Molecular Genetics. German Cancer Research Center (DKFZ)) ; Lichter, P. (Division of Molecular Genetics. German Cancer Research Center (DKFZ)) ; Alsop, K. (Sir Peter MacCallum Department of Oncology. Peter MacCallum Cancer Centre. University of Melbourne) ; Bruxner, T.J.C. (Queensland Centre for Medical Genomics. Institute for Molecular Bioscience. The University of Queensland) ; Christ, A.N. (Queensland Centre for Medical Genomics. Institute for Molecular Bioscience. The University of Queensland) ; Cordner, S.M. (Victorian Institute of Forensic Medicine) ; Cowin, P.A. (Peter MacCallum Cancer Centre. University of Melbourne) ; Drapkin, R. (University of Pennsylvania) ; Fereday, S. (Peter MacCallum Cancer Centre. University of Melbourne) ; George, J. (The Jackson Laboratory for Genomic Medicine) ; Hamilton, A. (Peter MacCallum Cancer Centre. University of Melbourne) ; Holmes, O. (Institute for Molecular Bioscience. University of Queensland) ; Hung, J.A. (Department of Gynaecological Oncology. Westmead Hospital) ; Kassahn, K.S. (Genetics and Molecular Pathology. SA Pathology) ; Kazakoff, S.H. (Institute for Molecular Bioscience. University of Queensland) ; Kennedy, C.J. (Department of Gynaecological Oncology. Westmead Hospital) ; Leonard, C.R. (Institute for Molecular Bioscience. University of Queensland) ; Mileshkin, L. (Sir Peter MacCallum Department of Oncology. Peter MacCallum Cancer Centre. University of Melbourne) ; Miller, D.K. (Garvan Institute of Medical Research) ; Arnau, G.M. (Peter MacCallum Cancer Centre. University of Melbourne) ; Mitchell, C. (Peter MacCallum Cancer Centre. University of Melbourne) ; Newell, F. (Institute for Molecular Bioscience. University of Queensland) ; Nones, K. (Institute for Molecular Bioscience. University of Queensland) ; Patch, A.M. (Institute for Molecular Bioscience. University of Queensland) ; Quinn, M.C. (Institute for Molecular Bioscience. University of Queensland) ; Taylor, D.F. (Queensland Centre for Medical Genomics. Institute for Molecular Bioscience. The University of Queensland) ; Thorne, H. (Peter MacCallum Cancer Centre. University of Melbourne) ; Traficante, N. (Peter MacCallum Cancer Centre. University of Melbourne) ; Vedururu, R. (Peter MacCallum Cancer Centre. University of Melbourne) ; Waddell, N.M. (Institute for Molecular Bioscience. University of Queensland) ; Waring, P.M. (Department of Clinical Pathology. University of Melbourne) ; Wood, S. (Institute for Molecular Bioscience. University of Queensland) ; Xu, Q. (Institute for Molecular Bioscience. University of Queensland) ; deFazio, A. (Westmead Clinical School. The Westmead Institute for Medical Research) ; Anderson, M.J. (Queensland Centre for Medical Genomics. Institute for Molecular Bioscience. The University of Queensland) ; Antonello, D. (Department of Surgery. Pancreas Institute. University and Hospital Trust of Verona) ; Barbour, A.P. (Surgical Oncology Group. Diamantina Institute. The University of Queensland) ; Bassi, C. (Department of Surgery. Pancreas Institute. University and Hospital Trust of Verona) ; Bersani, S. (Department of Diagnostics and Public Health. University and Hospital Trust of Verona) ; Cataldo, I. (ARC-Net Centre for Applied Research on Cancer. University and Hospital Trust of Verona) ; Chantrill, L.A. (Illawarra Shoalhaven Local Health District L3 Illawarra Cancer Care Centre. Wollongong Hospital) ; Chiew, Y.E. (Centre for Cancer Research. The Westmead Institute for Medical Research. The University of Sydney) ; Chou, A. (Department of Pathology. University of Sydney) ; Cingarlini, S. (Medical Oncology. University and Hospital Trust of Verona) ; Cloonan, N. (School of Biological Sciences. The University of Auckland) ; Corbo, V. (Department of Pathology and Diagnostics. University and Hospital Trust of Verona) ; Davi, M.V. (Department of Medicine. Section of Endocrinology. University and Hospital Trust of Verona) ; Duthie, F.R. (Department of Pathology. Queen Elizabeth University Hospital) ; Gill, A.J. (Department of Pathology. University of Sydney) ; Graham, J.S. (Department of Medical Oncology. Beatson West of Scotland Cancer Centre) ; Harliwong, I. (Queensland Centre for Medical Genomics. Institute for Molecular Bioscience. The University of Queensland) ; Jamieson, N.B. (Academic Unit of Surgery. School of Medicine. College of Medical. Veterinary and Life Sciences. University of Glasgow. Glasgow Royal Infirmary) ; Johns, A.L. (Garvan Institute of Medical Research) ; Kench, J.G. (Tissue Pathology and Diagnostic Oncology. Royal Prince Alfred Hospital) ; Landoni, L. (Department of Surgery. Pancreas Institute. University and Hospital Trust of Verona) ; Lawlor, R.T. (ARC-Net Centre for Applied Research on Cancer. University and Hospital Trust of Verona) ; Mafficini, A. (ARC-Net Centre for Applied Research on Cancer. University and Hospital Trust of Verona) ; Merrett, N.D. (Discipline of Surgery. Western Sydney University) ; Miotto, M. (Department of Surgery. Pancreas Institute. University and Hospital Trust of Verona) ; Musgrove, E.A. (Wolfson Wohl Cancer Research Centre. Institute of Cancer Sciences. University of Glasgow) ; Nagrial, A.M. (The Kinghorn Cancer Centre. Cancer Division. Garvan Institute of Medical Research. University of New South Wales) ; Oien, K.A. (Institute of Cancer Sciences. College of Medical Veterinary and Life Sciences. University of Glasgow) ; Pajic, M. (The Kinghorn Cancer Centre. Cancer Division. Garvan Institute of Medical Research. University of New South Wales) ; Pinese, M. (The Kinghorn Cancer Centre. Cancer Division. Garvan Institute of Medical Research. University of New South Wales) ; Robertson, A.J. (Queensland Centre for Medical Genomics. Institute for Molecular Bioscience. The University of Queensland) ; Rooman, I. (The Kinghorn Cancer Centre. Cancer Division. Garvan Institute of Medical Research. University of New South Wales) ; Rusev, B.C. (ARC-Net Centre for Applied Research on Cancer. University and Hospital Trust of Verona) ; Samra, J.S. (Department of Pathology. University of Sydney) ; Scardoni, M. (Department of Diagnostics and Public Health. University and Hospital Trust of Verona) ; Scarlett, C.J. (School of Environmental and Life Sciences. Faculty of Science. The University of Newcastle) ; Scarpa, A. (ARC-Net Centre for Applied Research on Cancer. University and Hospital Trust of Verona) ; Sereni, E. (Department of Surgery. Pancreas Institute. University and Hospital Trust of Verona) ; Sikora, K.O. (ARC-Net Centre for Applied Research on Cancer. University and Hospital Trust of Verona) ; Simbolo, M. (Department of Pathology and Diagnostics. University and Hospital Trust of Verona) ; Taschuk, M.L. (Genome Informatics Program. Ontario Institute for Cancer Research) ; Toon, C.W. (The Kinghorn Cancer Centre. Cancer Division. Garvan Institute of Medical Research. University of New South Wales) ; Vicentini, C. (ARC-Net Centre for Applied Research on Cancer. University and Hospital Trust of Verona) ; Wu, J. (The Kinghorn Cancer Centre. Cancer Division. Garvan Institute of Medical Research. University of New South Wales) ; Zeps, N. (Epworth HealthCare) ; Behren, A. (Olivia Newton-John Cancer Research Institute. La Trobe University) ; Burke, H. (Melanoma Institute Australia. The University of Sydney) ; Cebon, J. (Olivia Newton-John Cancer Research Institute. La Trobe University) ; Dagg, R.A. (Children's Hospital at Westmead. The University of Sydney) ; De Paoli-Iseppi, R. (Melanoma Institute Australia. The University of Sydney) ; Dutton-Regester, K. (Department of Genetics and Computational Biology. QIMR Berghofer Medical Research Institute) ; Field, M.A. (Australian Institute of Tropical Health and Medicine. James Cook University) ; Fitzgerald, A. (Bioplatforms Australia) ; Hersey, P. (Melanoma Institute Australia. The University of Sydney) ; Jakrot, V. (Melanoma Institute Australia. The University of Sydney) ; Johansson, P.A. (Department of Genetics and Computational Biology. QIMR Berghofer Medical Research Institute) ; Kakavand, H. (Melanoma Institute Australia. The University of Sydney) ; Kefford, R.F. (Melanoma Institute Australia. Macquarie University) ; Lau, L.M.S. (Children's Medical Research Institute) ; Long, G.V. (Melanoma Institute Australia. The University of Sydney) ; Pickett, H.A. (Children's Medical Research Institute) ; Pritchard, A.L. (Department of Genetics and Computational Biology. QIMR Berghofer Medical Research Institute) ; Pupo, G.M. (Centre for Cancer Research. The Westmead Millennium Institute for Medical Research. University of Sydney. Westmead Hospital) ; Saw, R.P.M. (Melanoma Institute Australia. The University of Sydney) ; Schramm, S.J. (Translational Cancer Research Centre. The University of Sydney at the Westmead Institute) ; Shang, C.A. (Bioplatforms Australia) ; Shang, P. (Melanoma Institute Australia. The University of Sydney) ; Spillane, A.J. (Melanoma Institute Australia. The University of Sydney) ; Stretch, J.R. (Melanoma Institute Australia. The University of Sydney) ; Tembe, V. (Translational Cancer Research Centre. The University of Sydney at the Westmead Institute) ; Thompson, J.F. (Melanoma Institute Australia. The University of Sydney) ; Vilain, R.E. (Discipline of Pathology. Sydney Medical School. The University of Sydney) ; Wilmott, J.S. (Melanoma Institute Australia. The University of Sydney) ; Yang, J.Y. (School of Mathematics and Statistics. The University of Sydney) ; Hayward, N.K. (Melanoma Institute Australia. The University of Sydney) ; Mann, G.J. (Melanoma Institute Australia. The University of Sydney) ; Scolyer, R.A. (Royal Prince Alfred Hospital) ; Bartlett, J. (Ontario Tumour Bank. Ontario Institute for Cancer Research) ; Bavi, P. (PanCuRx Translational Research Initiative. Ontario Institute for Cancer Research) ; Chadwick, D.E. (BioSpecimen Sciences Program. University Health Network) ; Chan-Seng-Yue, M. (PanCuRx Translational Research Initiative. Ontario Institute for Cancer Research) ; Cleary, S. (Hepatobiliary/Pancreatic Surgical Oncology Program. University Health Network) ; Connor, A.A. (Lunenfeld-Tanenbaum Research Institute. Mount Sinai Hospital) ; Czajka, K. (Genomics Research Program. Ontario Institute for Cancer Research) ; Denroche, R.E. (PanCuRx Translational Research Initiative. Ontario Institute for Cancer Research) ; Dhani, N.C. (Division of Medical Oncology. Princess Margaret Cancer Centre) ; Eagles, J. (Genomics Research Program. Ontario Institute for Cancer Research) ; Gallinger, S. (Lunenfeld-Tanenbaum Research Institute. Mount Sinai Hospital) ; Grant, R.C. (Lunenfeld-Tanenbaum Research Institute. Mount Sinai Hospital) ; Hedley, D. (Division of Medical Oncology. Princess Margaret Cancer Centre) ; Hollingsworth, M.A. (University of Nebraska Medical Center) ; Jang, G.H. (PanCuRx Translational Research Initiative. Ontario Institute for Cancer Research) ; Johns, J. (Genomics Research Program. Ontario Institute for Cancer Research) ; Kalimuthu, S. (PanCuRx Translational Research Initiative. Ontario Institute for Cancer Research) ; Liang, S.B. (BioSpecimen Sciences Program. University Health Network) ; Lungu, I. (Transformative Pathology. Ontario Institute for Cancer Research) ; Luo, X. (Computational Biology Program. Ontario Institute for Cancer Research) ; Mbabaali, F. (Genomics Research Program. Ontario Institute for Cancer Research) ; McPherson, T.A. (Lunenfeld-Tanenbaum Research Institute. Mount Sinai Hospital) ; Miller, J.K. (Genomics Research Program. Ontario Institute for Cancer Research) ; Moore, M.J. (Division of Medical Oncology. Princess Margaret Cancer Centre) ; Notta, F. (University Health Network. Princess Margaret Cancer Centre) ; Pasternack, D. (Genomics Research Program. Ontario Institute for Cancer Research) ; Petersen, G.M. (Department of Health Sciences Research. Mayo Clinic) ; Roehrl, M.H.A. (Department of Pathology. Human Oncology and Pathogenesis Program. Memorial Sloan Kettering Cancer Center) ; Sam, M. (Genomics Research Program. Ontario Institute for Cancer Research) ; Selander, I. (Lunenfeld-Tanenbaum Research Institute. Mount Sinai Hospital) ; Serra, S. (Department of Clinical Pathology. University of Melbourne) ; Shahabi, S. (BioSpecimen Sciences Program. University Health Network) ; Thayer, S.P. (University of Nebraska Medical Center) ; Timms, L.E. (Genomics Research Program. Ontario Institute for Cancer Research) ; Wilson, G.W. (PanCuRx Translational Research Initiative. Ontario Institute for Cancer Research) ; Wilson, J.M. (PanCuRx Translational Research Initiative. Ontario Institute for Cancer Research) ; Wouters, B.G. (Department of Medical Biophysics. University of Toronto) ; McPherson, J.D. (Department of Biochemistry and Molecular Medicine. University California at Davis) ; Beck, T.A. (Human Longevity) ; Bhandari, V. (Computational Biology Program. Ontario Institute for Cancer Research) ; Collins, C.C. (Vancouver Prostate Centre) ; Fleshner, N.E. (Department of Surgical Oncology. Princess Margaret Cancer Centre) ; Fox, N.S. (Computational Biology Program. Ontario Institute for Cancer Research) ; Fraser, M. (Computational Biology Program. Ontario Institute for Cancer Research) ; Heisler, L.E. (Genome Informatics Program. Ontario Institute for Cancer Research) ; Lalonde, E. (Computational Biology Program. Ontario Institute for Cancer Research) ; Livingstone, J. (Computational Biology Program. Ontario Institute for Cancer Research) ; Meng, A. (STTARR Innovation Facility. Princess Margaret Cancer Centre) ; Sabelnykova, V.Y. (Computational Biology Program. Ontario Institute for Cancer Research) ; Shiah, Y.J. (Computational Biology Program. Ontario Institute for Cancer Research) ; Van der Kwast, T. (Department of Pathology. Toronto General Hospital) ; Bristow, R.G. (Radiation Medicine Program. Princess Margaret Cancer Centre) ; Ding, S. (Hefei University of Technology) ; Fan, D. (State Key Laboratory of Cancer Biology and Xijing Hospital of Digestive Diseases. Fourth Military Medical University) ; Li, L. (BGI-Shenzhen) ; Nie, Y. (Fourth Military Medical University) ; Xiao, X. (School of Computer Science and Technology. Xi'an Jiaotong University) ; Xing, R. (Laboratory of Molecular Oncology. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education). Peking University Cancer Hospital & Institute) ; Yang, S. (Hefei University of Technology) ; Yu, Y. (Department of Surgery. Ruijin Hospital. Shanghai Jiaotong University School of Medicine) ; Zhou, Y. (BGI-Shenzhen) ; Banks, R.E. (Leeds Institute of Medical Research. University of Leeds. St James's University Hospital) ; Bourque, G. (Department of Human Genetics. McGill University) ; Brennan, P. (International Agency for Research on Cancer) ; Letourneau, L. (McGill University and Genome Quebec Innovation Centre) ; Riazalhosseini, Y. (Department of Human Genetics. McGill University) ; Scelo, G. (International Agency for Research on Cancer) ; Vasudev, N. (St James Institute of Oncology. University of Leeds. St James's University Hospital) ; Viksna, J. (Institute of Mathematics and Computer Science. University of Latvia) ; Lathrop, M. (Department of Human Genetics. McGill University) ; Tost, J. (Centre National de Génotypage. CEA - Institute de Génomique) ; Ahn, S.M. (Department of Oncology. Gil Medical Center. Gachon University) ; Aparicio, S. (Department of Molecular Oncology. BC Cancer Agency) ; Arnould, L. (Los Alamos National Laboratory) ; Aure, M.R. (Department of Genetics. Institute for Cancer Research. Oslo University Hospital. The Norwegian Radium Hospital) ; Bhosle, S.G. (Wellcome Sanger Institute) ; Birney, E. (European Molecular Biology Laboratory (EMBL). European Bioinformatics Institute (EMBL-EBI)) ; Borg, A. (Lund University) ; Boyault, S. (Translational Research Lab. Centre Léon Bérard) ; Brinkman, A.B. (Department of Molecular Biology. Faculty of Science. Radboud Institute for Molecular Life Sciences. Radboud University) ; Brock, J.E. (Department of Pathology. Brigham and Women's Hospital. Harvard Medical School) ; Broeks, A. (Department of Molecular Pathology. The Netherlands Cancer Institute) ; Børresen-Dale, A.L. (Department of Genetics. Institute for Cancer Research. Oslo University Hospital. The Norwegian Radium Hospital) ; Caldas, C. (Department of Oncology. University of Cambridge) ; Chin, S.F. (Department of Oncology. University of Cambridge) ; Davies, H. (Wellcome Sanger Institute) ; Desmedt, C. (Laboratory for Translational Breast Cancer Research. Department of Oncology. KU Leuven) ; Dirix, L. (Translational Cancer Research Unit. GZA Hospitals St-Augustinus. Center for Oncological Research. Faculty of Medicine and Health Sciences. University of Antwerp) ; Dronov, S. (Wellcome Sanger Institute) ; Ehinger, A. (Department of Gynecology & Obstetrics and Department of Clinical Sciences. Skåne University Hospital. Lund University) ; Eyfjord, J.E. (Icelandic Cancer Registry. Icelandic Cancer Society) ; Fatima, A. (Department of Cancer Biology. Dana-Farber Cancer Institute) ; Foekens, J.A. (Department of Medical Oncology. Josephine Nefkens Institute and Cancer Genomics Centre. Erasmus Medical Center) ; Futreal, P.A. (National Genotyping Center. Institute of Biomedical Sciences. Academia Sinica) ; Garred, Ø. (Faculty of Medicine and Institute of Clinical Medicine. University of Oslo) ; Giri, D.D. (Department of Pathology. Memorial Sloan Kettering Cancer Center) ; Glodzik, D. (Wellcome Sanger Institute) ; Grabau, D. (Department of Pathology. Skåne University Hospital. Lund University) ; Hilmarsdottir, H. (Icelandic Cancer Registry. Icelandic Cancer Society) ; Hooijer, G.K. (Department of Pathology. Academic Medical Center) ; Jacquemier, J. (Department of Pathology. College of Medicine. Hanyang University) ; Jang, S.J. (Department of Pathology. Asan Medical Center. College of Medicine. Ulsan University. Songpa-gu) ; Jonasson, J.G. (Icelandic Cancer Registry. Icelandic Cancer Society) ; Jonkers, J. (The Netherlands Cancer Institute) ; Kim, H.Y. (Department of Pathology. College of Medicine. Hanyang University) ; King, T.A. (Department of Surgery. Memorial Sloan Kettering Cancer Center) ; Knappskog, S. (Wellcome Sanger Institute) ; Kong, G. (Department of Pathology. College of Medicine. Hanyang University) ; Krishnamurthy, S. (Morgan Welch Inflammatory Breast Cancer Research Program and Clinic. The University of Texas MD Anderson Cancer Center) ; Lakhani, S.R. (The University of Queensland Centre for Clinical Research. The Royal Brisbane & Women's Hospital) ; Langerød, A. (Department of Genetics. Institute for Cancer Research. Oslo University Hospital. The Norwegian Radium Hospital) ; Larsimont, D. (Department of Pathology. Institut Jules Bordet) ; Lee, H.J. (Department of Pathology. Asan Medical Center. College of Medicine. Ulsan University. Songpa-gu) ; Lee, J.Y. (Institute for Bioengineering and Biopharmaceutical Research (IBBR). Hanyang University) ; Lee, M.T.M. (National Genotyping Center. Institute of Biomedical Sciences. Academia Sinica) ; Lingjærde, O.C. (University of Oslo) ; MacGrogan, G. (Institut Bergonié) ; Martens, J.W.M. (Department of Medical Oncology. Josephine Nefkens Institute and Cancer Genomics Centre. Erasmus Medical Center) ; O'Meara, S. (Wellcome Sanger Institute) ; Pauporté, I. (Institut National du Cancer (INCA)) ; Pinder, S. (Department of Research Oncology. Guy's Hospital. King's Health Partners AHSC. King's College London School of Medicine) ; Pivot, X. (University Hospital of Minjoz. INSERM UMR 1098) ; Provenzano, E. (Cambridge Breast Unit. Addenbrooke's Hospital. Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre) ; Purdie, C.A. (East of Scotland Breast Service. Ninewells Hospital) ; Ramakrishna, M. (Wellcome Sanger Institute) ; Ramakrishnan, K. (Wellcome Sanger Institute) ; Reis-Filho, J. (Department of Pathology. Memorial Sloan Kettering Cancer Center) ; Richardson, A.L. (Department of Cancer Biology. Dana-Farber Cancer Institute) ; Ringnér, M. (Lund University) ; Rodriguez, J.B. (Barcelona Supercomputing Center (BSC)) ; Rodríguez-González, F.G. (University of Copenhagen) ; Romieu, G. (Oncologie Sénologie. ICM Institut Régional du Cancer) ; Salgado, R. (Department of Clinical Pathology. University of Melbourne) ; Sauer, T. (University of Oslo) ; Shepherd, R. (Wellcome Sanger Institute) ; Sieuwerts, A.M. (Department of Medical Oncology. Josephine Nefkens Institute and Cancer Genomics Centre. Erasmus Medical Center) ; Simpson, P.T. (The University of Queensland Centre for Clinical Research. The Royal Brisbane & Women's Hospital) ; Smid, M. (Department of Medical Oncology. Josephine Nefkens Institute and Cancer Genomics Centre. Erasmus Medical Center) ; Sotiriou, C. (University of California San Diego) ; Span, P.N. (Department of Radiation Oncology. Radboud University Nijmegen Medical Centre) ; Stefánsson, Ó.A. (University of Iceland) ; Stenhouse, A. (Dundee Cancer Centre. Ninewells Hospital) ; Stunnenberg, H.G. (Institut Curie. INSERM Unit 830) ; Sweep, F. (Department of Laboratory Medicine. Radboud University Nijmegen Medical Centre) ; Tan, B.K.T. (Department of General Surgery. Singapore General Hospital) ; Thomas, G. (INCa-Synergie. Centre Léon Bérard. Universite Lyon) ; Thompson, A.M. (Dundee Cancer Centre. Ninewells Hospital) ; Tommasi, S. (Giovanni Paolo II/I.R.C.C.S. Cancer Institute) ; Treilleux, I. (Université Claude Bernard Lyon 1) ; Tutt, A. (Department of Cancer Biology. Dana-Farber Cancer Institute) ; Ueno, N.T. (The University of Texas MD Anderson Cancer Center) ; Van Laere, S. (Translational Cancer Research Unit. GZA Hospitals St-Augustinus. Center for Oncological Research. Faculty of Medicine and Health Sciences. University of Antwerp) ; Van den Eynden, G.G. (Translational Cancer Research Unit. GZA Hospitals St-Augustinus. Center for Oncological Research. Faculty of Medicine and Health Sciences. University of Antwerp) ; Vermeulen, P. (Translational Cancer Research Unit. GZA Hospitals St-Augustinus. Center for Oncological Research. Faculty of Medicine and Health Sciences. University of Antwerp) ; Viari, A. (ARC-Net Centre for Applied Research on Cancer. University and Hospital Trust of Verona) ; Vincent-Salomon, A. (Institut Curie. INSERM Unit 830) ; Wong, B.H. (NCCS-VARI Translational Research Laboratory. National Cancer Centre Singapore) ; Yates, L. (Wellcome Sanger Institute) ; Zou, X. (Wellcome Sanger Institute) ; van Deurzen, C.H.M. (Department of Pathology. Erasmus Medical Center Rotterdam) ; van de Vijver, M.J. (Department of Clinical Pathology. University of Melbourne) ; van't Veer, L. (Division of Molecular Carcinogenesis. The Netherlands Cancer Institute) ; Ammerpohl, O. (University Hospital of Ulm) ; Aukema, S. (Hematopathology Section. Institute of Pathology. Christian-Albrechts-University) ; Bergmann, A.K. (Department of Human Genetics. Hannover Medical School) ; Bernhart, S.H. (Transcriptome Bioinformatics. LIFE Research Center for Civilization Diseases. University of Leipzig) ; Borkhardt, A. (Department of Pediatric Oncology. Hematology and Clinical Immunology. Heinrich-Heine-University) ; Borst, C. (Department of Internal Medicine/Hematology. Friedrich-Ebert-Hospital) ; Burkhardt, B. (Pediatric Hematology and Oncology. University Hospital Muenster) ; Claviez, A. (Department of Pediatrics. University Hospital Schleswig-Holstein) ; Goebler, M.E. (Department of Medicine II. University of Würzburg) ; Haake, A. (Institute of Human Genetics. Christian-Albrechts-University) ; Haas, S. (Department of Internal Medicine/Hematology. Friedrich-Ebert-Hospital) ; Hansmann, M. (Senckenberg Institute of Pathology. University of Frankfurt Medical School) ; Hoell, J.I. (Department of Pediatric Oncology. Hematology and Clinical Immunology. Heinrich-Heine-University) ; Hummel, M. (Institute of Pathology. Charité-University Medicine Berlin) ; Karsch, D. (Department for Internal Medicine II. University Hospital Schleswig-Holstein) ; Klapper, W. (Hematopathology Section. Institute of Pathology. Christian-Albrechts-University) ; Kneba, M. (Department for Internal Medicine II. University Hospital Schleswig-Holstein) ; Kreuz, M. (Institute for Medical Informatics Statistics and Epidemiology. University of Leipzig) ; Kube, D. (Department of Hematology and Oncology. Georg-Augusts-University of Göttingen) ; Küppers, R. (Institute of Cell Biology (Cancer Research). University of Duisburg-Essen) ; Lenze, D. (Institute of Pathology. Charité-University Medicine Berlin) ; Loeffler, M. (Institute for Medical Informatics Statistics and Epidemiology. University of Leipzig) ; López, C. (Institute of Human Genetics. Christian-Albrechts-University) ; Mantovani-Löffler, L. (MVZ Department of Oncology. PraxisClinic am Johannisplatz) ; Möller, P. (Institute of Pathology. Ulm University and University Hospital of Ulm) ; Ott, G. (Department of Pathology. Robert-Bosch-Hospital) ; Radlwimmer, B. (Division of Molecular Genetics. German Cancer Research Center (DKFZ)) ; Richter, J. (Hematopathology Section. Institute of Pathology. Christian-Albrechts-University) ; Rohde, M. (Pediatric Hematology and Oncology. University Hospital Giessen) ; Rosenstiel, P.C. (Institute of Clinical Molecular Biology. Christian-Albrechts-University) ; Rosenwald, A. (Institute of Pathology. University of Wuerzburg) ; Schilhabel, M.B. (Institute of Clinical Molecular Biology. Christian-Albrechts-University) ; Schreiber, S. (Department of General Internal Medicine. University Kiel) ; Stadler, P.F. (Transcriptome Bioinformatics. LIFE Research Center for Civilization Diseases. University of Leipzig) ; Staib, P. (Clinic for Hematology and Oncology. St-Antonius-Hospital) ; Stilgenbauer, S. (Department for Internal Medicine III. University of Ulm and University Hospital of Ulm) ; Sungalee, S. (European Molecular Biology Laboratory (EMBL). Genome Biology Unit) ; Szczepanowski, M. (Hematopathology Section. Institute of Pathology. Christian-Albrechts-University) ; Toprak, U.H. (Neuroblastoma Genomics. German Cancer Research Center (DKFZ)) ; Trümper, L.H.P. (Department of Hematology and Oncology. Georg-Augusts-University of Göttingen) ; Wagener, R. (Institute of Human Genetics. Christian-Albrechts-University) ; Zenz, T. (National Center for Tumor Diseases (NCT) Heidelberg) ; Hovestadt, V. (Division of Molecular Genetics. German Cancer Research Center (DKFZ)) ; von Kalle, C. (German Cancer Research Center (DKFZ)) ; Kool, M. (Hopp Children's Cancer Center (KiTZ)) ; Korshunov, A. (Functional and Structural Genomics. German Cancer Research Center (DKFZ)) ; Landgraf, P. (University of Düsseldorf) ; Lehrach, H. (Department of Vertebrate Genomics/Otto Warburg Laboratory Gene Regulation and Systems Biology of Cancer. Max Planck Institute for Molecular Genetics) ; Northcott, P.A. (St Jude Children's Research Hospital) ; Pfister, S.M. (Heidelberg University Hospital) ; Reifenberger, G. (University of Düsseldorf) ; Warnatz, H.J. (Department of Vertebrate Genomics/Otto Warburg Laboratory Gene Regulation and Systems Biology of Cancer. Max Planck Institute for Molecular Genetics) ; Wolf, S. (Genomics and Proteomics Core Facility High Throughput Sequencing Unit. German Cancer Research Center (DKFZ)) ; Yaspo, M.L. (Department of Vertebrate Genomics/Otto Warburg Laboratory Gene Regulation and Systems Biology of Cancer. Max Planck Institute for Molecular Genetics) ; Assenov, Y. (Epigenomics and Cancer Risk Factors. German Cancer Research Center (DKFZ)) ; Gerhauser, C. (Cancer Epigenomics. German Cancer Research Center (DKFZ)) ; Minner, S. (University Medical Center Hamburg-Eppendorf) ; Schlomm, T. (Martini-Clinic. Prostate Cancer Center. University Medical Center Hamburg-Eppendorf) ; Simon, R. (Institute of Pathology. University Medical Center Hamburg-Eppendorf) ; Sauter, G. (Institute of Pathology. University Medical Center Hamburg-Eppendorf) ; Sültmann, H. (Division of Cancer Genome Research. German Cancer Research Center (DKFZ)) ; Biswas, N.K. (National Institute of Biomedical Genomics) ; Maitra, A. (National Institute of Biomedical Genomics) ; Majumder, P.P. (National Institute of Biomedical Genomics) ; Sarin, R. (Advanced Centre for Treatment Research & Education in Cancer. Tata Memorial Centre) ; Barbi, S. (Department of Pathology and Diagnostics. University and Hospital Trust of Verona) ; Bonizzato, G. (ARC-Net Centre for Applied Research on Cancer. University and Hospital Trust of Verona) ; Cantù, C. (ARC-Net Centre for Applied Research on Cancer. University and Hospital Trust of Verona) ; Dei Tos, A.P. (Department of Pathology. General Hospital of Treviso. Department of Medicine. University of Padua) ; Fassan, M. (Department of Medicine (DIMED). Surgical Pathology Unit. University of Padua) ; Grimaldi, S. (ARC-Net Centre for Applied Research on Cancer. University and Hospital Trust of Verona) ; Luchini, C. (Department of Diagnostics and Public Health. University and Hospital Trust of Verona) ; Malleo, G. (Department of Surgery. Pancreas Institute. University and Hospital Trust of Verona) ; Marchegiani, G. (Department of Surgery. Pancreas Institute. University and Hospital Trust of Verona) ; Milella, M. (Medical Oncology. University and Hospital Trust of Verona) ; Paiella, S. (Department of Surgery. Pancreas Institute. University and Hospital Trust of Verona) ; Pea, A. (Department of Surgery. Pancreas Institute. University and Hospital Trust of Verona) ; Pederzoli, P. (Department of Surgery. Pancreas Institute. University and Hospital Trust of Verona) ; Ruzzenente, A. (Department of Surgery. Pancreas Institute. University and Hospital Trust of Verona) ; Salvia, R. (Department of Surgery. Pancreas Institute. University and Hospital Trust of Verona) ; Sperandio, N. (ARC-Net Centre for Applied Research on Cancer. University and Hospital Trust of Verona) ; Arai, Y. (Division of Cancer Genomics. National Cancer Center Research Institute. National Cancer Center) ; Hama, N. (Division of Cancer Genomics. National Cancer Center Research Institute. National Cancer Center) ; Hiraoka, N. (Department of Hepatobiliary and Pancreatic Oncology. Hepatobiliary and Pancreatic Surgery Division. Division of Pathology and Clinical Laboratories. National Cancer Center Hospital. Chuo-ku) ; Hosoda, F. (Division of Cancer Genomics. National Cancer Center Research Institute. National Cancer Center) ; Nakamura, H. (Division of Cancer Genomics. National Cancer Center Research Institute. National Cancer Center) ; Ojima, H. (Department of Pathology. Keio University School of Medicine) ; Okusaka, T. (Department of Hepatobiliary and Pancreatic Oncology. National Cancer Center Hospital) ; Totoki, Y. (Division of Cancer Genomics. National Cancer Center Research Institute. National Cancer Center) ; Urushidate, T. (Laboratory of Molecular Medicine. Human Genome Center. The Institute of Medical Science. The University of Tokyo) ; Fukayama, M. (Department of Pathology. Graduate School of Medicine. The University of Tokyo. Bunkyo-ku) ; Ishikawa, S. (Preventive Medicine. Graduate School of Medicine. The University of Tokyo) ; Katai, H. (Gastric Surgery Division. Division of Pathology and Clinical Laboratories. National Cancer Center Hospital) ; Katoh, H. (Preventive Medicine. Graduate School of Medicine. The University of Tokyo) ; Komura, D. (Preventive Medicine. Graduate School of Medicine. The University of Tokyo) ; Rokutan, H. (Department of Bioinformatics. Division of Cancer Genomics. National Cancer Center Research Institute. National Cancer Center) ; Saito-Adachi, M. (Department of Bioinformatics. Division of Cancer Genomics. National Cancer Center Research Institute. National Cancer Center) ; Suzuki, A. (Department of Gastroenterology and Hepatology. Yokohama City University Graduate School of Medicine) ; Taniguchi, H. (Laboratory of Molecular Medicine. Human Genome Center. The Institute of Medical Science. University of Tokyo) ; Tatsuno, K. (Genome Science Division. Research Center for Advanced Science and Technology. The University of Tokyo) ; Ushiku, T. (Department of Pathology. Graduate School of Medicine. The University of Tokyo. Bunkyo-ku) ; Yachida, S. (Department of Cancer Genome Informatics. Graduate School of Medicine. Osaka University) ; Yamamoto, S. (Genome Science Division. Research Center for Advanced Science and Technology. The University of Tokyo) ; Aikata, H. (Hiroshima University) ; Arihiro, K. (Hiroshima University) ; Ariizumi, S.i. (Tokyo Women's Medical University) ; Chayama, K. (Hiroshima University) ; Furuta, M. (RIKEN Center for Integrative Medical Sciences) ; Gotoh, K. (Osaka International Cancer Center) ; Hayami, S. (Wakayama Medical University) ; Hirano, S. (Hokkaido University) ; Kawakami, Y. (Hiroshima University) ; Maejima, K. (RIKEN Center for Integrative Medical Sciences) ; Nakamura, T. (Hokkaido University) ; Nakano, K. (RIKEN Center for Integrative Medical Sciences) ; Ohdan, H. (Hiroshima University) ; Sasaki-Oku, A. (RIKEN Center for Integrative Medical Sciences) ; Tanaka, H. (The Institute of Medical Science. The University of Tokyo) ; Ueno, M. (Wakayama Medical University) ; Yamamoto, M. (Tokyo Women's Medical University) ; Yamaue, H. (Wakayama Medical University) ; Choo, S.P. (Division of Medical Oncology. National Cancer Centre) ; Cutcutache, I. (Centre for Computational Biology. Duke-NUS Medical School) ; Khuntikeo, N. (Cholangiocarcinoma Screening and Care Program and Liver Fluke and Cholangiocarcinoma Research Centre. Faculty of Medicine. Khon Kaen University) ; Ong, C.K. (Lymphoma Genomic Translational Research Laboratory. National Cancer Centre) ; Pairojkul, C. (Department of Clinical Pathology. University of Melbourne) ; Popescu, I. (Center of Digestive Diseases and Liver Transplantation. Fundeni Clinical Institute) ; Ahn, K.S. (Division of Hepatobiliary and Pancreatic Surgery. Department of Surgery. School of Medicine. Keimyung University Dongsan Medical Center) ; Aymerich, M. (Pathology. Hospital Clinic. Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). University of Barcelona) ; Lopez-Guillermo, A. (Hematology. Hospital Clinic. Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). University of Barcelona) ; López-Otín, C. (Department of Biochemistry and Molecular Biology. Faculty of Medicine. University Institute of Oncology-IUOPA) ; Puente, X.S. (Department of Biochemistry and Molecular Biology. Faculty of Medicine. University Institute of Oncology-IUOPA) ; Campo, E. (Spanish Ministry of Science and Innovation) ; Amary, F. (Royal National Orthopaedic Hospital (Bolsover)) ; Baumhoer, D. (Department of Pathology. Oslo University Hospital. The Norwegian Radium Hospital) ; Behjati, S. (Wellcome Sanger Institute) ; Bjerkehagen, B. (Institute of Clinical Medicine and Institute of Oral Biology. University of Oslo) ; Futreal, P.A. (National Genotyping Center. Institute of Biomedical Sciences. Academia Sinica) ; Myklebost, O. (Department of Clinical Science. University of Bergen) ; Pillay, N. (Research Department of Pathology. University College London Cancer Institute) ; Tarpey, P. (East Anglian Medical Genetics Service. Cambridge University Hospitals NHS Foundation Trust) ; Tirabosco, R. (Royal National Orthopaedic Hospital (Stanmore)) ; Zaikova, O. (Division of Orthopaedic Surgery. Oslo University Hospital) ; Flanagan, A.M. (Department of Pathology (Research). University College London Cancer Institute) ; Boultwood, J. (Radcliffe Department of Medicine. University of Oxford) ; Bowen, D.T. (Wellcome Sanger Institute) ; Cazzola, M. (University of Pavia) ; Green, A.R. (University of Cambridge) ; Hellstrom-Lindberg, E. (Karolinska Institute) ; Malcovati, L. (University of Pavia) ; Nangalia, J. (Wellcome Sanger Institute) ; Papaemmanuil, E. (Wellcome Sanger Institute) ; Vyas, P. (University of Oxford) ; Ang, Y. (Salford Royal NHS Foundation Trust) ; Barr, H. (Gloucester Royal Hospital) ; Beardsmore, D. (Royal Stoke University Hospital) ; Eldridge, M. (Cancer Research UK Cambridge Institute. University of Cambridge) ; Gossage, J. (St Thomas's Hospital) ; Grehan, N. (MRC Cancer Unit. University of Cambridge) ; Hanna, G.B. (Imperial College NHS Trust. Imperial College London) ; Hayes, S.J. (Faculty of Biology. Medicine and Health. The University of Manchester) ; Hupp, T.R. (Edinburgh Royal Infirmary) ; Khoo, D. (Barking Havering and Redbridge University Hospitals NHS Trust) ; Lagergren, J. (King's College London and Guy's and St Thomas' NHS Foundation Trust) ; Lovat, L.B. (University College London) ; MacRae, S. (Cancer Unit. MRC University of Cambridge) ; O'Donovan, M. (MRC Cancer Unit. University of Cambridge) ; O'Neill, J.R. (Cambridge Oesophagogastric Centre. Cambridge University Hospitals NHS Foundation Trust) ; Parsons, S.L. (Nottingham University Hospitals NHS Trust) ; Preston, S.R. (St Luke's Cancer Centre. Royal Surrey County Hospital NHS Foundation Trust) ; Puig, S. (University of North Carolina at Chapel Hill) ; Roques, T. (Norfolk and Norwich University Hospital NHS Trust) ; Sanders, G. (Lineberger Comprehensive Cancer Center. University of North Carolina at Chapel Hill) ; Sothi, S. (University Hospitals Coventry and Warwickshire NHS Trust) ; Tavaré, S. (Cancer Research UK Cambridge Institute. University of Cambridge) ; Tucker, O. (University Hospitals Birmingham NHS Foundation Trust) ; Turkington, R. (Centre for Cancer Research and Cell Biology. Queen's University) ; Underwood, T.J. (School of Cancer Sciences. Faculty of Medicine. University of Southampton) ; Welch, I. (Wythenshawe Hospital) ; Fitzgerald, R.C. (MRC Cancer Unit. University of Cambridge) ; Berney, D.M. (Barts Cancer Institute. Barts and the London School of Medicine and Dentistry. Queen Mary University of London) ; De Bono, J.S. (The Institute of Cancer Research) ; Cahill, D. (Royal Marsden NHS Foundation Trust. London and Sutton) ; Camacho, N. (The Institute of Cancer Research) ; Dennis, N.M. (Royal Marsden NHS Foundation Trust. London and Sutton) ; Dudderidge, T. (University Hospital Southampton NHS Foundation Trust) ; Edwards, S.E. (The Institute of Cancer Research) ; Fisher, C. (Royal Marsden NHS Foundation Trust. London and Sutton) ; Foster, C.S. (University of Liverpool) ; Ghori, M. (Wellcome Sanger Institute) ; Gill, P. (University of Oxford) ; Gnanapragasam, V.J. (Academic Urology Group. Department of Surgery. University of Cambridge) ; Gundem, G. (Memorial Sloan Kettering Cancer Center) ; Hamdy, F.C. (University of Oxford. Oxford) ; Hawkins, S. (Cancer Research UK Cambridge Institute. University of Cambridge) ; Hazell, S. (Royal Marsden NHS Foundation Trust. London and Sutton) ; Howat, W. (Cambridge University Hospitals NHS Foundation Trust) ; Isaacs, W.B. (Department of Urology. James Buchanan Brady Urological Institute. Johns Hopkins University School of Medicine) ; Karaszi, K. (University of Oxford) ; Kay, J.D. (University College London) ; Khoo, V. (Royal Marsden NHS Foundation Trust. London and Sutton) ; Kote-Jarai, Z. (The Institute of Cancer Research) ; Kremeyer, B. (Wellcome Sanger Institute) ; Kumar, P. (Royal Marsden NHS Foundation Trust. London and Sutton) ; Lambert, A. (University of Oxford) ; Leongamornlert, D.A. (Wellcome Sanger Institute) ; Livni, N. (Royal Marsden NHS Foundation Trust. London and Sutton) ; Lu, Y.J. (Second Military Medical University) ; Luxton, H.J. (University College London) ; Marsden, L. (University of Oxford) ; Massie, C.E. (Cancer Research UK Cambridge Institute. University of Cambridge) ; Matthews, L. (The Institute of Cancer Research) ; Mayer, E. (Department of Surgery and Cancer. Imperial College London) ; McDermott, U. (Wellcome Sanger Institute) ; Merson, S. (The Institute of Cancer Research) ; Neal, D.E. (Cambridge University Hospitals NHS Foundation Trust) ; Ng, A. (The Chinese University of Hong Kong) ; Nicol, D. (Royal Marsden NHS Foundation Trust. London and Sutton) ; Ogden, C. (Royal Marsden NHS Foundation Trust. London and Sutton) ; Rowe, E.W. (Royal Marsden NHS Foundation Trust. London and Sutton) ; Shah, N.C. (Cambridge University Hospitals NHS Foundation Trust) ; Thomas, S. (Royal Marsden NHS Foundation Trust. London and Sutton) ; Thompson, A. (Royal Marsden NHS Foundation Trust. London and Sutton) ; Verrill, C. (Nuffield Department of Surgical Sciences. John Radcliffe Hospital. University of Oxford. Headington) ; Visakorpi, T. (Faculty of Medicine and Health Technology. Tampere University and Tays Cancer Center. Tampere University Hospital) ; Warren, A.Y. (Department of Histopathology. Cambridge University Hospitals NHS Foundation Trust) ; Whitaker, H.C. (University College London) ; Zhang, H. (Center for Molecular Oncology. Memorial Sloan Kettering Cancer Center) ; van As, N. (Royal Marsden NHS Foundation Trust. London and Sutton) ; Eeles, R.A. (Royal Marsden NHS Foundation Trust. London and Sutton) ; Abeshouse, A. (Memorial Sloan Kettering Cancer Center) ; Agrawal, N. (University of Chicago) ; Akbani, R. (Department of Bioinformatics and Computational Biology and Department of Systems Biology. The University of Texas MD Anderson Cancer Center) ; Al-Ahmadie, H. (Memorial Sloan Kettering Cancer Center) ; Albert, M. (Ontario Tumour Bank. Ontario Institute for Cancer Research) ; Aldape, K. (Laboratory of Pathology. Center for Cancer Research. National Cancer Institute) ; Ally, A. (Canada's Michael Smith Genome Sciences Center. BC Cancer Agency) ; Appelbaum, E.L. (University College London) ; Armenia, J. (Center for Molecular Oncology. Memorial Sloan Kettering Cancer Center) ; Asa, S. (University Health Network) ; Auman, J.T. (Department of Pathology and Laboratory Medicine. School of Medicine. University of North Carolina at Chapel Hill) ; Balasundaram, M. (Canada's Michael Smith Genome Sciences Center. BC Cancer Agency) ; Balu, S. (Lineberger Comprehensive Cancer Center. University of North Carolina at Chapel Hill) ; Barnholtz-Sloan, J. (Research Health Analytics and Informatics. University Hospitals Cleveland Medical Center) ; Bathe, O.F. (Department of Surgery and Department of Oncology. University of Calgary) ; Baylin, S.B. (University Hospital Southampton NHS Foundation Trust) ; Benz, C. (Buck Institute for Research on Aging) ; Berchuck, A. (Duke University Medical Center) ; Berrios, M. (USC Norris Comprehensive Cancer Center. University of Southern California) ; Bigner, D. (The Preston Robert Tisch Brain Tumor Center. Duke University Medical Center) ; Birrer, M. (Massachusetts General Hospital) ; Bodenheimer, T. (Lineberger Comprehensive Cancer Center. University of North Carolina at Chapel Hill) ; Boice, L. (University of North Carolina at Chapel Hill) ; Bootwalla, M.S. (USC Norris Comprehensive Cancer Center. University of Southern California) ; Bosenberg, M. (Department of Dermatology and Department of Pathology. Yale University) ; Bowlby, R. (Canada's Michael Smith Genome Sciences Center. BC Cancer Agency) ; Boyd, J. (Fox Chase Cancer Center) ; Broaddus, R.R. (Department of Pathology. The University of Texas MD Anderson Cancer Center) ; Brock, M. (Department of Surgery. Division of Thoracic Surgery. The Johns Hopkins University School of Medicine) ; Brooks, D. (Canada's Michael Smith Genome Sciences Center. BC Cancer Agency) ; Bullman, S. (Department of Medical Oncology. Dana-Farber Cancer Institute) ; Caesar-Johnson, S.J. (National Cancer Institute. National Institutes of Health) ; Carey, T.E. (University of Michigan Comprehensive Cancer Center) ; Carlsen, R. (Canada's Michael Smith Genome Sciences Center. BC Cancer Agency) ; Cerfolio, R. (University of Alabama at Birmingham) ; Chandan, V.S. (Division of Anatomic Pathology. Mayo Clinic) ; Chen, H.W. (Center for Molecular Oncology. Memorial Sloan Kettering Cancer Center) ; Cherniack, A.D. (Department of Medical Oncology. Dana-Farber Cancer Institute) ; Chien, J. (Division of Experimental Pathology. Mayo Clinic) ; Cho, J. (Broad Institute of MIT and Harvard) ; Chuah, E. (Canada's Michael Smith Genome Sciences Center. BC Cancer Agency) ; Cibulskis, C. (Broad Institute of MIT and Harvard) ; Cope, L. (Department of Oncology. The Johns Hopkins School of Medicine. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University) ; Cordes, M.G. (Norfolk and Norwich University Hospital NHS Trust) ; Curley, E. (International Genomics Consortium) ; Czerniak, B. (Barking Havering and Redbridge University Hospitals NHS Trust) ; Danilova, L. (Department of Oncology. The Johns Hopkins School of Medicine. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University) ; Davis, I.J. (Department of Pediatrics and Department of Genetics. University of North Carolina at Chapel Hill) ; Defreitas, T. (Broad Institute of MIT and Harvard) ; Demchok, J.A. (National Cancer Institute. National Institutes of Health) ; Dhalla, N. (Canada's Michael Smith Genome Sciences Center. BC Cancer Agency) ; Dhir, R. (Department of Pathology. UPMC Shadyside) ; Doddapaneni, H.V. (Human Genome Sequencing Center. Baylor College of Medicine) ; El-Naggar, A. (Barking Havering and Redbridge University Hospitals NHS Trust) ; Felau, I. (National Cancer Institute. National Institutes of Health) ; Ferguson, M.L. (Center for Cancer Genomics. National Cancer Institute. National Institutes of Health) ; Finocchiaro, G. (Department of Neuro-Oncology. Istituto Neurologico Besta) ; Fong, K.M. (University of Queensland Thoracic Research Centre. The Prince Charles Hospital) ; Frazer, S. (Broad Institute of MIT and Harvard) ; Friedman, W. (Department of Neurosurgery. University of Florida) ; Fronick, C.C. (Norfolk and Norwich University Hospital NHS Trust) ; Fulton, L.A. (The McDonnell Genome Institute. Washington University) ; Gabriel, S.B. (Broad Institute of MIT and Harvard) ; Gao, J. (Center for Molecular Oncology. Memorial Sloan Kettering Cancer Center) ; Gehlenborg, N. (Center for Biomedical Informatics. Harvard Medical School) ; Gershenwald, J.E. (Department of Surgical Oncology. The University of Texas MD Anderson Cancer Center) ; Ghossein, R. (Department of Pathology. Memorial Sloan Kettering Cancer Center) ; Giama, N.H. (Division of Gastroenterology and Hepatology. Mayo Clinic) ; Gibbs, R.A. (Human Genome Sequencing Center. Baylor College of Medicine) ; Gomez, C. (Sylvester Comprehensive Cancer Center. University of Miami) ; Govindan, R. (Alvin J. Siteman Cancer Center. Washington University School of Medicine) ; Hayes, D.N. (University of Tennessee Health Science Center for Cancer Research) ; Hegde, A.M. (Department of Bioinformatics and Computational Biology and Department of Systems Biology. The University of Texas MD Anderson Cancer Center) ; Heiman, D.I. (Broad Institute of MIT and Harvard) ; Heins, Z. (Memorial Sloan Kettering Cancer Center) ; Hepperla, A.J. (Lineberger Comprehensive Cancer Center. University of North Carolina at Chapel Hill) ; Holbrook, A. (USC Norris Comprehensive Cancer Center. University of Southern California) ; Holt, R.A. (Canada's Michael Smith Genome Sciences Center. BC Cancer Agency) ; Hoyle, A.P. (Lineberger Comprehensive Cancer Center. University of North Carolina at Chapel Hill) ; Hruban, R.H. (Department of Oncology. The Johns Hopkins School of Medicine. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University) ; Hu, J. (Human Genome Sequencing Center. Baylor College of Medicine) ; Huang, M. (University of North Carolina at Chapel Hill) ; Huntsman, D. (Centre for Translational and Applied Genomics. British Columbia Cancer Agency) ; Huse, J. (Memorial Sloan Kettering Cancer Center) ; Iacobuzio-Donahue, C.A. (Department of Pathology. Memorial Sloan Kettering Cancer Center) ; Ittmann, M. (Michael E. DeBakey Veterans Affairs Medical Center) ; Jayaseelan, J.C. (Human Genome Sequencing Center. Baylor College of Medicine) ; Jefferys, S.R. (Lineberger Comprehensive Cancer Center. University of North Carolina at Chapel Hill) ; Jones, C.D. (Carolina Center for Genome Sciences. University of North Carolina at Chapel Hill) ; Jones, S.J.M. (Canada's Michael Smith Genome Sciences Centre. BC Cancer Agency) ; Juhl, H. (Indivumed) ; Kang, K.J. (Division of Hepatobiliary and Pancreatic Surgery. Department of Surgery. School of Medicine. Keimyung University Dong-san Medical Center) ; Karlan, B. (Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute. Cedars-Sinai Medical Center) ; Kasaian, K. (Canada's Michael Smith Genome Sciences Centre. BC Cancer Agency) ; Kebebew, E. (Endocrine Oncology Branch. Center for Cancer Research. National Cancer Institute. National Institutes of Health) ; Kim, H.K. (National Cancer Center) ; Korchina, V. (Human Genome Sequencing Center. Baylor College of Medicine) ; Kundra, R. (Center for Molecular Oncology. Memorial Sloan Kettering Cancer Center) ; Lai, P.H. (USC Norris Comprehensive Cancer Center. University of Southern California) ; Lander, E. (Broad Institute of MIT and Harvard) ; Le, X. (ILSbio. LLC Biobank) ; Lee, D. (Canada's Michael Smith Genome Sciences Center. BC Cancer Agency) ; Levine, D.A. (Gynecologic Oncology. NYU Laura and Isaac Perlmutter Cancer Center. New York University) ; Lewis, L. (Human Genome Sequencing Center. Baylor College of Medicine) ; Ley, T. (Division of Oncology. Stem Cell Biology Section. Washington University School of Medicine) ; Li, H.I. (Canada's Michael Smith Genome Sciences Center. BC Cancer Agency) ; Lin, P. (Broad Institute of MIT and Harvard) ; Linehan, W.M. (Urologic Oncology Branch. Center for Cancer Research. National Cancer Institute. National Institutes of Health) ; Liu, F.F. (University of Toronto) ; Lu, Y. (Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education). Peking University Cancer Hospital & Institute) ; Lype, L. (Institute for Systems Biology) ; Ma, Y. (Canada's Michael Smith Genome Sciences Center. BC Cancer Agency) ; Maglinte, D.T. (Center for Personalized Medicine. Department of Pathology and Laboratory Medicine. Children's Hospital Los Angeles) ; Mardis, E.R. (Institute for Genomic Medicine. Nationwide Children's Hospital) ; Marks, J. (Department of Surgery. Duke University) ; Marra, M.A. (Canada's Michael Smith Genome Sciences Center. BC Cancer Agency) ; Matthew, T.J. (University of California Santa Cruz) ; Mayo, M. (Canada's Michael Smith Genome Sciences Center. BC Cancer Agency) ; McCune, K. (Department of Obstetrics. Gynecology and Reproductive Services. University of California San Francisco) ; Meier, S.R. (Broad Institute of MIT and Harvard) ; Meng, S. (Lineberger Comprehensive Cancer Center. University of North Carolina at Chapel Hill) ; Mieczkowski, P.A. (Department of Genetics. University of North Carolina at Chapel Hill) ; Mikkelsen, T. (Department of Neurology and Department of Neurosurgery. Henry Ford Hospital) ; Miller, C.A. (The McDonnell Genome Institute. Washington University) ; Mills, G.B. (Knight Cancer Institute. Oregon Health & Science University) ; Moore, R.A. (Canada's Michael Smith Genome Sciences Center. BC Cancer Agency) ; Morrison, C. (Department of Pathology. Roswell Park Cancer Institute) ; Mose, L.E. (Lineberger Comprehensive Cancer Center. University of North Carolina at Chapel Hill) ; Moser, C.D. (Division of Gastroenterology and Hepatology. Mayo Clinic) ; Mungall, A.J. (Canada's Michael Smith Genome Sciences Center. BC Cancer Agency) ; Mungall, K. (Canada's Michael Smith Genome Sciences Center. BC Cancer Agency) ; Mutch, D. (Department of Obstetrics and Gynecology. Division of Gynecologic Oncology. Washington University School of Medicine) ; Muzny, D.M. (Department of Palliative. Rehabilitation and Integrative Medicine. The University of Texas MD Anderson Cancer Center) ; Myers, J. (Penrose St Francis Health Services) ; Newton, Y. (University of California Santa Cruz) ; Noble, M.S. (Broad Institute of MIT and Harvard) ; O'Donnell, P. (The University of Chicago) ; O'Neill, B.P. (Department of Neurology. Mayo Clinic) ; Ochoa, A. (Memorial Sloan Kettering Cancer Center) ; Park, J.W. (Center for Liver Cancer. Research Institute and Hospital. National Cancer Center) ; Parker, J.S. (Department of Genetics and Lineberger Comprehensive Cancer Center. University of North Carolina at Chapel Hill) ; Pass, H. (NYU Langone Medical Center) ; Pastore, A. (Computational Biology Center. Memorial Sloan Kettering Cancer Center) ; Pennell, N.A. (Department of Hematology and Medical Oncology. Cleveland Clinic) ; Perou, C.M. (Department of Genetics. Department of Pathology and Laboratory Medicine. School of Medicine. University of North Carolina at Chapel Hill) ; Petrelli, N. (Helen F. Graham Cancer Center at Christiana Care Health Systems) ; Potapova, O. (Cureline) ; Rader, J.S. (Department of Obstetrics and Gynecology. Medical College of Wisconsin) ; Ramalingam, S. (Hematology and Medical Oncology. Winship Cancer Institute of Emory University) ; Rathmell, W.K. (Vanderbilt Ingram Cancer Center. Vanderbilt University) ; Reuter, V. (Department of Pathology. Memorial Sloan Kettering Cancer Center) ; Reynolds, S.M. (Institute for Systems Biology) ; Ringel, M. (Ohio State University College of Medicine and Arthur G. James Comprehensive Cancer Center) ; Roach, J. (Research Computing Center. University of North Carolina at Chapel Hill) ; Roberts, L.R. (Division of Gastroenterology and Hepatology. Mayo Clinic) ; Robertson, A.G. (Canada's Michael Smith Genome Sciences Center. BC Cancer Agency) ; Sadeghi, S. (Canada's Michael Smith Genome Sciences Center. BC Cancer Agency) ; Saller, C. (Analytical Biological Services) ; Sanchez-Vega, F. (Center for Molecular Oncology. Memorial Sloan Kettering Cancer Center) ; Schadendorf, D. (Department of Dermatology. University Hospital Essen. Westdeutsches Tumorzentrum and German Cancer Consortium) ; Schein, J.E. (Canada's Michael Smith Genome Sciences Center. BC Cancer Agency) ; Schmidt, H.K. (The McDonnell Genome Institute. Washington University) ; Schultz, N. (Center for Molecular Oncology. Memorial Sloan Kettering Cancer Center) ; Seethala, R. (University of Pittsburgh) ; Senbabaoglu, Y. (Computational Biology Center. Memorial Sloan Kettering Cancer Center) ; Shelton, T. (International Genomics Consortium) ; Shi, Y. (Lineberger Comprehensive Cancer Center. University of North Carolina at Chapel Hill) ; Shih, J. (Department of Medical Oncology. Dana-Farber Cancer Institute) ; Shmulevich, I. (Institute for Systems Biology) ; Shriver, C. (Murtha Cancer Center. Walter Reed National Military Medical Center) ; Signoretti, S. (Brigham and Women's Hospital. Harvard Medical School) ; Simons, J.V. (Lineberger Comprehensive Cancer Center. University of North Carolina at Chapel Hill) ; Singer, S. (Department of Surgery. Memorial Sloan Kettering Cancer Center) ; Sipahimalani, P. (Canada's Michael Smith Genome Sciences Center. BC Cancer Agency) ; Skelly, T.J. (Department of Genetics. University of North Carolina at Chapel Hill) ; Smith-McCune, K. (Department of Obstetrics. Gynecology and Reproductive Services. University of California San Francisco) ; Socci, N.D. (Computational Biology Center. Memorial Sloan Kettering Cancer Center) ; Soloway, M.G. (Department of Genetics and Lineberger Comprehensive Cancer Center. University of North Carolina at Chapel Hill) ; Sood, A.K. (Department of Gynecologic Oncology and Reproductive Medicine. and Center for RNA Interference and Non-Coding RNA. The University of Texas MD Anderson Cancer Center) ; Tam, A. (Canada's Michael Smith Genome Sciences Center. BC Cancer Agency) ; Tan, D. (Department of Genetics. University of North Carolina at Chapel Hill) ; Tarnuzzer, R. (National Cancer Institute. National Institutes of Health) ; Thiessen, N. (Canada's Michael Smith Genome Sciences Center. BC Cancer Agency) ; Thompson, R.H. (Department of Urology. Mayo Clinic) ; Thorne, L.B. (University of North Carolina at Chapel Hill) ; Tsao, M. (University Health Network) ; Umbricht, C. (Department of Surgery. Johns Hopkins University School of Medicine) ; Van Den Berg, D.J. (USC Norris Comprehensive Cancer Center. University of Southern California) ; Van Meir, E.G. (Department of Neurosurgery. Department of Hematology and Department of Medical Oncology. Winship Cancer Institute and School of Medicine. Emory University) ; Veluvolu, U. (Department of Genetics. University of North Carolina at Chapel Hill) ; Voet, D. (Broad Institute of MIT and Harvard) ; Wang, L. (Human Genome Sequencing Center. Baylor College of Medicine) ; Weinberger, P. (Georgia Regents University Cancer Center) ; Weisenberger, D.J. (USC Norris Comprehensive Cancer Center. University of Southern California) ; Wigle, D. (Thoracic Oncology Laboratory. Mayo Clinic) ; Wilkerson, M.D. (Department of Genetics. University of North Carolina at Chapel Hill) ; Wilson, R.K. (Institute for Genomic Medicine. Nationwide Children's Hospital) ; Winterhoff, B. (Department of Obstetrics & Gynecology. Division of Gynecologic Oncology. Mayo Clinic) ; Wiznerowicz, M. (Poznan University of Medical Sciences) ; Wong, T. (Canada's Michael Smith Genome Sciences Center. BC Cancer Agency) ; Wong, W. (Edison Family Center for Genome Sciences and Systems Biology. Washington University) ; Xi, L. (Human Genome Sequencing Center. Baylor College of Medicine) ; Yau, C. (Buck Institute for Research on Aging) ; Zhang, H. (Center for Molecular Oncology. Memorial Sloan Kettering Cancer Center) ; Zhang, J. (National Cancer Institute. National Institutes of Health)
Cancer is driven by genetic change, and the advent of massively parallel sequencing has enabled systematic documentation of this variation at the whole-genome scale. Here we report the integrative analysis of 2,658 whole-cancer genomes and their matching normal tissues across 38 tumour types from the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium of the International Cancer Genome Consortium (ICGC) and The Cancer Genome Atlas (TCGA). [...]
2020 - 10.1038/s41586-020-1969-6
Nature, Vol. 578 (February 2020) , p. 82-93  
6.
24 p, 1.2 MB Llar, barri, ciutat i coespacialitat : sentit de lloc dels immigrants espanyols i italians a Mèxic / Oliveras González, Xavier (Universitat Autònoma de Barcelona. Departament de Geografia) ; Ortiz Guitart, Anna (Universitat Autònoma de Barcelona. Departament de Geografia) ; Mendoza Pérez, Cristóbal (Universidad Autónoma Metropolitana-Iztapalapa. Departamento de Sociología)
Aquest article analitza l'espai viscut i el sentit de lloc d'un grup d'immigrants qualificats procedents del sud d'Europa a Mèxic. Es parteix de la hipòtesi que la dimensió espacial d'"esdevenir local" és rellevant per al procés d'assentament i permanència dels migrants en el lloc de destinació. [...]
Este artículo analiza el espacio vivido y el sentido de lugar de un grupo de immigrantes cualificados procedentes del sur de Europa a México. Se parte de la hipótesis que la dimensión espacial de "convertirse en local" es relevante para el proceso de asentamiento y permanencia de los migrantes en el lugar de destinación. [...]
This article analyses the lived space and the sense of place of a group of skilled immigrants from southern Europe in Mexico. The hypothesis is that the spatial dimension of "becoming local" is relevant in the migrants' process of settlement and remaining at the country of destination. [...]

2019 - 10.2436/20.3002.01.175
Treballs de la Societat Catalana de Geografia, Núm. 87 (2019) , p. 123-146  
7.
Gentrification and health in two global cities : a call to identify impacts for socially-vulnerable residents / Anguelovski, Isabelle (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; Triguero Mas, Margarita (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; Connolly, James J. T. (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; Kotsila, Panagiota (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; Shokry, Galia (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; Pérez del Pulgar, Carmen (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; García-Lamarca, Melissa (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; Argüelles, Lucía (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; Mangione, Julia (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; Dietz, Kaitlyn (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; Cole, Helen (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals)
In global cities, the impacts of gentrification on the lives and well-being of socially vulnerable residents have occupied political agendas. Yet to date, research on how gentrification affects a multiplicity of health outcomes has remained scarce. [...]
2019 - 10.1080/23748834.2019.1636507
Cities and health, (July 2019)  
8.
14 p, 3.1 MB Cuando el planeamiento atrae el turismo : el caso del barrio del Raval / Porfido, Enrico (Universitat Politècnica de Catalunya. Institut Habitat, Turisme i Territori) ; Perez, Cynthia C. (Universitat Politècnica de Catalunya. Institut Habitat, Turisme i Territori) ; Pesoa, Melisa (Universitat Politècnica de Catalunya)
La presente contribución tiene por objeto reflexionar sobre la relación entre las herramientas y estrategias de planificación urbana y el desarrollo e impacto del turismo urbano en la ciudad de Barcelona, enfocándonos en la relación entre comercios y flujos turísticos. [...]
La present contribució té per objecte reflexionar sobre la relació entre les eines i estratègies de planificació urbana i el desenvolupament i impacte del turisme urbà a la ciutat de Barcelona, enfocant-nos en la relació entre comerços i fluxos turístics. [...]

2019
Papers : Regió Metropolitana de Barcelona : Territori, estratègies, planejament, Núm. 62 (Octubre 2019) , p. 78-91 (Articles)  
9.
38 p, 1.1 MB Urban green boosterism and city affordability : for whom is the 'branded' green city? / García-Lamarca, Melissa (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; Anguelovski, Isabelle (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; Cole, Helen (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; Connolly, James J. T. (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; Argüelles, Lucía (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; Baró Porras, Francesc (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; Loveless, Stephanie (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; Pérez del Pulgar, Carmen (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; Shokry, Galia (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals)
Increasingly, greening in cities across the Global North is enmeshed in strategies for attracting capital investment, raising the question: for whom is the future green city? Through exploring the relationship between cities' green boosterist rhetoric, affordability and social equity considerations within greening programmes, this paper examines the extent to which, and why, the degree of green branding - that is, urban green boosterism - predicts the variation in city affordability. [...]
2019 - 10.1177/0042098019885330
Urban Studies, (December 2019)  
10.
7 p, 266.7 KB Enriquecimiento ambiental y bienestar en peces / Villarroel Robinson, Morris (Universidad Politécnica de Madrid. Departamento de Producción Agraria) ; Torrent Bravo, Fernando (Universidad Politécnica de Madrid. Departamento de Ingeniería y Gestión Ambiental) ; Pérez Marcos, Concepción (Universidad Complutense de Madrid. Departamento de Fisiología) ; González de Chávarri, Elisabet (Universidad Complutense de Madrid) ; de la Fuente Vázquez, Jesús (Universidad Complutense de Madrid. Departamento de Producción Animal)
Revisamos la relación entre el enriquecimiento ambiental y el bienestar de los peces, incluido el enriquecimiento ocupacional. Explicamos los diferentes aspectos a tener en cuenta y concluimos que el enriquecimiento ocupacional no parece tener efectos negativos sobre el crecimiento y que puede ayudar a sobrellevar los efectos de un estresor agudo.
We review the relationship between environmental enrichment and fish welfare, including occupational enrichment. We explain the different aspects that should be taken into account and conclude that occupational enrichment does not appear to have negative effects on growth and that it can help to cope with acute stressors.

2019 - 10.5565/rev/da.458
dA Derecho Animal : Forum of Animal Law Studies, Vol. 10 Núm. 4 (2019) , p. 98-104 (Dossier temático)  

Articles : 103 records found   1 - 10nextend  jump to record:
Contributions to meetings and congresses 8 records found  
1.
9 p, 97.4 KB Mecanismos de la percepción en Madame Bovary y La Regenta : estudio comparativo / Pérez Pérez, Mª Concepción (Universidad de Sevilla)
El presente texto pretende ser una aportación al terreno de la literatura comparada, y más concretamente una contribución a los estudios centrados en la relación entre Madame Bovary y La Regenta. [...]
2012
Colloque de l'Asociación de Profesores de Francés de la Universidad Española. Barcelona-Bellaterra, 21r : 2012  
2.
2 p, 60.6 KB Adjustments in employment and wages in France : concessions bargaining in a time of crisis / Delahaie, Noélie (Institut de Recherches Economiques et Sociales) ; Pérez, Coralie (University of Paris 1 Panthéon-Sorbonne) ; Centre d'Estudis Sociològics sobre la Vida Quotidiana i el Treball
2016 (IWPLMS 2016 Book of abstracts)
Annual Conference of the International Working Party on Labour Market Segmentation. Barcelona, Catalunya, 37è : 2016  
3.
11 p, 209.4 KB Mecanismos de captura y desenganche en el procesamiento afectivo de participantes con ansiedad rasgo elevada vs. baja / Pérez-Dueñas, Carolina (Universidad de Granada. Departamento de Psicología Experimental y Fisiología del Comportamiento) ; Lupiañez, Juan (Universidad de Granada. Departamento de Psicología Experimental y Fisiología del Comportamiento) ; Acosta, Alberto (Universidad de Granada. Departamento de Psicología Experimental y Fisiología del Comportamiento) ; Universitat Autònoma de Barcelona. Departament de Psicologia Bàsica, Evolutiva i de l'Educació ; Reunión Científica sobre Atención (6a : 2007 : Barcelona, Catalunya)
[Barcelona] : Monflorit Edicions i Assessoraments, 2010
La atención (VI) : un enfoque pluridisciplinar, 2010, p. 177-187  
4.
7 p, 42.8 KB A study of the acquisition of english as a foreign language: integrating content and language in mainstream education in Barcelona / Pérez Vidal, Carme (Universitat Pompeu Fabra) ; Roquet i Pugés, Helena (Universitat Pompeu Fabra) ; Taula Rodona Internacional TRI-CLIL (2a : 2012 : Bellaterra, Catalunya)
2012
TRICLIL proceedings: Better CLIL: more opportunities in primary, secondary and higher education, 2012, p. 113-119  
5.
8 p, 51.3 KB The profile of the professional translator. Developing competencies for a rapid incorporation into the industry / Rico Pérez, Celia
A commitment to training translators in such a way as to enable them to be incorporated almost immediately into the working world is posing the agents responsible for drawing up curricular models, study plans and subject syllabuses the challenge of reconciling the sometimes-conflicting interests of academic training and the industry. [...]
2002 (Papers de Tradumàtica)
Simposi sobre l'Ensenyament a distància i semipresencial de la Tradumàtica, 1er : 2002  
6.
8 p, 51.3 KB El perfil del traductor profesional. Desarrollo de competencias para una rápida incorporación a la industria / Rico Pérez, Celia
El compromiso por formar traductores que puedan incorporarse al mundo laboral de manera casi inmediata lleva a los agentes encargados de elaborar modelos curriculares, planes de estudio y programas de asignaturas a asumir el desafío de conciliar los intereses, a veces encontrados, de la formación académica y la industria. [...]
2002 (Papers de Tradumàtica)
Simposi sobre l'Ensenyament a distància i semipresencial de la Tradumàtica, 1er : 2002  
7.
8 p, 51.6 KB El perfil del traductor professional. Desenvolupament de competències per a una ràpida incorporació a la indústria / Rico Pérez, Celia
El compromís per formar traductors que puguin incorporar-se al món laboral de manera quasi immediata porta als agents encarregats d'el·laborar models curriculars, plans d'estudi i programes d'assignatures a assumir el repte de conciliar els interessos, a vegades trobats, de la formació acadèmica i la indústria. [...]
2002 (Papers de Tradumàtica)
Simposi sobre l'Ensenyament a distància i semipresencial de la Tradumàtica, 1er : 2002  
8.
36 p, 303.3 KB 'To CLIL or not to CLIL...' : tot construint un projecte per a l'Europa Multilingüe / Pérez Vidal, Carmen ; Grup LIEC (Llengua i Ensenyament de les Ciències) ; Universitat Autònoma de Barcelona ; Universitat Pompeu Fabra ; Trobada sobre semi-immersió a Catalunya (3a : 2009 : Barcelona, Catalunya) ; Taula rodona internacional sobre programes AICLE (1a : 2009 : Barcelona, Catalunya)
'Europa será multilingüe o no será' es uno de los lemas con los que se clausuró en el 2001 el año Europeo de las lenguas. La diversidad lingüística y cultural de la nueva Europa se identificaba como un distintivo único, una riqueza social clave para conseguir avanzar hacia una Europa de las lenguas y del conocimiento. [...]
2009
Trobada sobre semi-immersió a Catalunya. Barcelona, Catalunya, 3a : 2009
Taula rodona internacional sobre programes AICLE. Barcelona, Catalunya, 1a : 2009  

Books and collections 7 records found  
1.
266 p, 11.9 MB GREEN TRAJECTORIES municipal policy trends and strategies for greening in Europe, Canada and United States (1990-2016) / Anguelovski, Isabelle (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; Argüelles, Lucía (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; Baró Porras, Francesc (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; Cole, Helen (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; Connolly, James J. T. (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; García-Lamarca, Melissa (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; Loveless, Stephanie (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; Pérez del Pulgar, Carmen (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; Shokry, Galia (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; Trebic, Tatjana (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; Wood, Erin (Institut Hospital del Mar d'Investigacions Mèdiques)
This book examines the urban greening policy trajectories of 50 cities in Europe, Canada and the United States over the last 25 years. It identifies the main trends and strategies used and ranks cities along key criteria including the level of rhetoric, focus on health, and equitable access. [...]
2018  
2.
232 p, 2.5 MB Tendencias en políticas educativas sobre derechos humanos e inclusión. Implicaciones en la gestión de las instituciones iberoamericanas de educación superior / Gairín Sallán, Joaquín, coord. ; Suárez, Cecilia Inés, coord. ; Alonso Jiménez, María Teresa ; López Soligo, Marina Ancona ; Arce González, Consuelo ; Barrales Villegas, Adoración ; Brito Delgado, Juana María ; Bizelli, José Luis ; Bañol Pérez, Carolina ; Bolaños Prado, Elena ; Chevalier, Carolina ; Coeto Calcáneo, Irma Alejandra ; Corea Tórrez, Norma Cándida ; Donoso Díaz, Sebastián ; Garzón Castrillón, Ana ; González Rubio, Janeth ; Guerrero Rodríguez, Lilia Esther ; Leiva G. María Verónica ; Lopes Reis, Márcia ; Moya Padilla, Nereyda E. ; Musselli, Sharon ; Neto e Matos, Rui Manuel ; Nossar, Karina ; Medrano Rodríguez, Hernán ; Palmeros Ávila, Guadalupe ; Reyes A., Daniel ; Román Medina, Luciano ; Sánchez Díaz, Sebastián ; Sandoval Manríquez, Mario ; Sarasola, Marcos ; Scaffo, Sonia ; Serentil Rubio, Josep ; Suárez Díaz, Guadalupe ; Tafur Puente, Rosa ; Terreros Barrios, Nicolasa ; Tejera, Andrea ; Vázquez, María Inés
Santiago de Chile : Santillana, 2017 (Informes ; 9)  
3.
38 p, 1.0 MB Guía para la evaluación de repositorios institucionales de investigación / Barrueco Cruz, José Manuel (Universitat de València) ; Andrés Rodríguez, Aurelia (Fundación Española para la Ciencia y la Tecnología) ; Rico Castro, Pilar (Fundación Española para la Ciencia y la Tecnología) ; Coslado Bernabé, Mª Ángeles (Fundación Española para la Ciencia y la Tecnología) ; Azorín, Cristina (Universitat Autònoma de Barcelona) ; Bernal Martínez, Isabel (Consejo Superior de Investigaciones Científicas) ; Cívico Martín, Rafaela (Universidad de Huelva) ; Cózar Santiago, Amparo (Universidad de Navarra) ; Guzmán Pérez, Catalina (Universidad de Córdoba) ; Losada Yáñez, Marina (Universitat Pompeu Fabra) ; Morillo Moreno, José Carlos (Universidad de Huelva) ; Nonó Rius, Brigit (Universitat de Girona) ; Padrós Cuxart, Rosa (Universitat Oberta de Catalunya) ; Prats Prat, Jordi (Universitat Politècnica de Catalunya)
Esta nueva versión de la Guía para la evaluación de repositorios institucionales de investigación tiene como finalidad principal el seguir siendo instrumento de auditoría interna para mejorar la calidad de los repositorios. [...]
Madrid: Fecyt, 2017  
4.
57 p, 37.6 MB Alonso Berruguete en el Retablo de San Benito el Real de Valladolid : discurso leído ante la Real Academia de Bellas Artes de la Purísima Concepción de Valladolid por D. Constantino Candeira Pérez en su recepción pública el día 23 de Enero de 1960 y contestación de Don Francisco Anton Caseca Académico de Número de la Corporación / Candeira Pérez, Constantino ; Anton Caseca, Francisco ; Berruguete, Alonso
Discurs llegit per Constantino Candeira Pérez en motiu del seu ingrés a la Real Academia de Bellas Artes de la Purísima Concepción de Valladolid l'any 1960. L'estudi tracta sobre el retaule de San Benito el Real de Valladolid, obra d'Alonso Berruguete. [...]
Discurso leído por Constantino Candeira Pérez en motivo de su ingreso en la Real Academia de Bellas Artes de la Purísima Concepción de Valladolid en 1960. El estudio trata sobre el retablo de San Benito el Real de Valladolid, obra de Alonso Berruguete. [...]
Speech read by Constantino Candeira Pérez on the occasion of his admission to the Royal Academy of Fine Arts of the Purísima Concepción in Valladolid in 1960. The study deals with the altarpiece of San Benito el Real by Alonso Berruguete in Valladolid. [...]

1960  
5.
230 p, 581.8 KB Propostes d'intervenció per a la conciliació d'horaris familiars, escolars i laborals : informe final / Cardús i Ros, Salvador, 1954- (Universitat Autònoma de Barcelona. Departament de Sociologia) ; Pérez i Sánchez, Carmen ; Morral i Gimeno, Sergi ; Catalunya. Departament de Benestar i Família
Barcelona : Generalitat de Catalunya, Departament de Benestar i Família, 2003  
6.
11 p, 209.4 KB Mecanismos de captura y desenganche en el procesamiento afectivo de participantes con ansiedad rasgo elevada vs. baja / Pérez-Dueñas, Carolina (Universidad de Granada. Departamento de Psicología Experimental y Fisiología del Comportamiento) ; Lupiañez, Juan (Universidad de Granada. Departamento de Psicología Experimental y Fisiología del Comportamiento) ; Acosta, Alberto (Universidad de Granada. Departamento de Psicología Experimental y Fisiología del Comportamiento) ; Universitat Autònoma de Barcelona. Departament de Psicologia Bàsica, Evolutiva i de l'Educació ; Reunión Científica sobre Atención (6a : 2007 : Barcelona, Catalunya)
[Barcelona] : Monflorit Edicions i Assessoraments, 2010
La atención (VI) : un enfoque pluridisciplinar, 2010, p. 177-187  
7.
15 p, 2.1 MB La Morbimortalidad infantil institucional de León / Pérez Delgado, C.
Madrid : Ministerio de la Gobernación, Dirección General de Sanidad, Servicios Centrales de Higiene Infantil, 1955 (Al Servicio de España y del Niño español ; 212)  

Research literature 67 records found  1 - 10nextend  jump to record:
1.
9 p, 734.3 KB Creació d'una app de Chatbot integrable a App de missatgeria i apps webs / Valero Pérez, Carlos ; Giner Miguelez, Joan, dir. (Universitat Autònoma de Barcelona. Departament d'Enginyeria de la Informació i de les Comunicacions) ; Universitat Autònoma de Barcelona. Escola d'Enginyeria
Donada la gran quantitat de demanda d'informació que els centres educatius han d'assumir cada cop que comença un nou curs acadèmic, sorgeix la necessitat de facilitar la feina a les persones encarregades d'atendre aquesta demanda. [...]
Dada la gran demanda de información que deben asumir las escuelas cada vez que se inicia un nuevo curso académico, surge la necesidad de facilitar la labor de los responsables de atender esa demanda. [...]
Given the large amount of demand for information that schools must assume each time a new academic year begins, the need to facilitate the work of those responsible for meeting this demand arises. Chatbots, also know as virtual assistants, are able to simulate a conversation with a human being by giving automated answers to the questions raised. [...]

2020
Enginyeria Informàtica [958]  
2.
23 p, 174.0 KB Economia social i solidària i ruralitat : reptes i potencialitats / Escarrà Pérez, Carla ; Griera Llonch, Eudald, dir. ; Universitat Autònoma de Barcelona. Facultat d'Economia i Empresa
La següent investigació te per objectiu fer una aproximació als conceptes d'economia social i solidària i ruralitat al principat català. Partint d'un anàlisi històric que situa les problemàtiques actuals dels entorns rurals, el text analitza els reptes d'aquests a través de projectes vinculats al moviment d'economia social i solidària que treballen per revertir-los. [...]
La siguiente investigación tiene por objectivo llevar a cabo una aproximación a los conceptos de economia social i solidária i ruralidad en el principado catalán. Partiendo del análisis histórico en el que se enmarcan las problemáticas actuales de los entornos rurales, el texto analiza los desafíos de los mismos a partir de proyectos vinculados a la economía social i solidaria que trabajan para revertir-los. [...]
The aim of the following research is to make an approach at the concepts of social economics and rural enviroment in Catalunya. Starting from an historic analysis that situates the ongoing problematic of the rural environments, the text analyses the challenges of these through projects linked with the movement of social economics that work to revert them. [...]

2020
Postgrau en Economia Social i Solidària: Desenvolupament Local, Cooperativisme i Transformació Social [3780]  
3.
29 p, 437.2 KB La renovación del poder : Gramsci y Foucault / Solorzano Perez, Juan Carlos ; Mir Garcia, Jordi, dir. (Universitat Autònoma de Barcelona. Departament de Ciència Política i de Dret Públic) ; Universitat Autònoma de Barcelona. Facultat de Ciències Polítiques i de Sociologia
Este trabajo sobretodo se centrará ver las potencialidades de análisis de las perspectivas del poder en Antonio Gramsci y Michel Foucault. En el caso de Gramsci el avance del fascismo y en caso de Foucault el caso de la emergencia del neoliberalismo. [...]
2020
Grau en Ciència Política i Gestió Pública [818]
3 documents
4.
70 p, 3.1 MB Canvis en la caracterització de bones activitats matemàtiques en un context de desenvolupament professional per a mestres de primària / Pérez Pérez, Carla, autor ; Badillo Jiménez, Edelmira Rosa, tutora ; Couso, Digna, tutora ; Universitat Autònoma de Barcelona. Facultat de Ciències de l'Educació
L'objectiu principal d'aquest treball de final de màster és identificar quins canvis es produeixen en mestres de primària respecte a la caracterització de bones activitats matemàtiques, al llarg d'una formació que busca el desenvolupament professional. [...]
Bellaterra, setembre 2019  
5.
37 p, 280.3 KB Sociodemografia y migración transnacional México-Estados Unidos : aportes para una reflexión teórica / Mendoza Pérez, Cristóbal
Es reflexiona críticament sobre l'aportació que ha fet la sociodemografia al debat sobre transnacionalisme en la migració Mèxic-Estats Units. En primer lloc, es revisa l'aportació de la sociodemografia a l'estudi de la dimensió temporal del fenomen migratori, per posteriorment estudiar les diferents perspectives teòriques que han analitzat la construcció d'espais transnacionals, diferenciant, en aquest apartat, entre espais polítics econòmics i socials transnacionals. [...]
Este artículo reflexiona críticamente sobre la aportación que ha hecho la sociodemografía al debate sobre transnacionalismo en la migración México-Estados Unidos. En primer lugar se revisa la aportación de la sociodemografía al estudio de la dimensión temporal del fenómeno migratorio, posteriormente se estudian los diferentes enfoques teóricos que han abordado la construcción de espacios transnacionales, distinguiendo, en este apartado, entre espacios políticos, económicos y sociales transnacionales. [...]
This article critically reflects on the contribution that social demography has made to the debate on transnationalism in migration from Mexico to the United States. In the first place the contribution from social demography to the study of the temporality of migration is reviewed, followed by the study of the different theoretical approaches that have embarked on the construction of transnational spaces, distinguishing, in this section, between political, economic and social spaces. [...]
On présente ici une réflexion critique sur les apports des travaux de démographie sociale au débat sur le supranationalisme dans les courants migratoires du Mexique vers les États-Unis. En premier lieu on révise l'apport de la démographie sociale à l'étude de la dimension temporelle du phénomène migratoire, et ensuite on étudie les différentes approches théoriques qui ont abordé la construction d'espaces transnationaux, en distinguant entre les espaces politiques, économiques et sociaux. [...]

Bellaterra Centre d'Estudis Demogràfics 2005 (Papers de demografia (Centre d'Estudis Demogràfics) ; 261)  
6.
80 p, 3.2 MB Detección de noticias a través de aplicaciones de inteligencia artificial : la inteligencia artificial aplicada a informativos 2019-2020 / Ruiz, José Juan (RTVE) ; Vila, Pere (RTVE) ; Corral, David (RTVE) ; Pérez, Carmen (RTVE) ; Crespo, Esteban (RTVE) ; Mayoral, Esteban (RTVE) ; Martín, Miguel Ángel (RTVE) ; Cánovas, Pedro (RTVE) ; Pérez Tornero, José Manuel (Universitat Autònoma de Barcelona) ; Pulido, Cristina (Universitat Autònoma de Barcelona) ; Tejedor, Santiago (Universitat Autònoma de Barcelona) ; Cervi, Laura (Universitat Autònoma de Barcelona) ; Sanjinés, Diana (Universitat Autònoma de Barcelona) ; Zhang, Wei (Universitat Autònoma de Barcelona) ; Samy Tayie, Sally (Universitat Autònoma de Barcelona)
Este informe - intitulado Detección de noticias a través de aplicaciones de inteligencia artificial- se inscribe en el marco de un proceso de investigación centrado en la innovación del periodismo audiovisual, que Radio Televisión Española (RTVE) y la Universidad Autónoma de Barcelona (UAB) pusieron en marcha en el año 2015, año en el que se constituye el Observatorio para la Innovación de las Informativos en la Sociedad de la información (OI2) y se crea una cátedra conjunta sobre el mismo tema. [...]
Barcelona: Observatorio para la Innovación de los Informativos en la Sociedad Digital (OI2), RTVE, 2019  
7.
132 p, 14.7 MB Pla de Comunicación per a Gòtic Terapèutic Center / Pérez García, Cantia ; Cara Ibar, Jordi, dir. (Universitat Autònoma de Barcelona. Departament de Publicitat, Relacions Públiques i Comunicació Audiovisual) ; Universitat Autònoma de Barcelona. Facultat de Ciències de la Comunicació
El següent projecte consisteix en un pla de comunicació per a un centre especialitzat en dietètica i teràpies naturals, anomenat Gòtic Terapèutic Center. El pla té com a objectiu principal millorar la comunicació del centre a partir d'haver realitzat una investigació sobre el context i la seva competència. [...]
El siguiente proyecto consiste en un plan de comunicación para un centro especializado en dietética y terapias naturales, llamado Gòtic Terapèutic Center. El plan tiene como objetivo principal mejorar la comunicación del centro a partir de haber realizado una investigación sobre el contexto y su competencia. [...]
The next project consists of a communication plan for a center specialized in dietetics and natural therapies, called Gòtic Terapèutic Center. The main objective of the plan is to improve the communication of the center by having carried out an investigation into the context and its competence. [...]

2019
Grau en Publicitat i Relacions Públiques [972]  
8.
224 p, 17.0 MB Plan de comunicación de una App intermediaria para el sector del taxi adaptada a la situación actual / Pérez Berrio, Cristina ; Campmany Muñoz, Miquel, dir. (Universitat Autònoma de Barcelona. Departament de Publicitat, Relacions Públiques i Comunicació Audiovisual) ; Universitat Autònoma de Barcelona. Facultat de Ciències de la Comunicació
El projecte consisteix en la creació d'un pla de comunicació per a una nova aplicació. Sorgeix a partir de la desconfiança acumulada en el sector del taxi que va créixer després dels esdeveniments que van passar a les vagues del 2018 i 2019 contra les VTC. [...]
El proyecto consiste en la creación de un plan de comunicación para una nueva aplicación. Surge a partir de la desconfianza acumulada en el sector del taxi que creció después de los eventos que pasaron en las huelgas del 2018 y 2019 contra las VTC. [...]
The project consists of creating a communication plan for a new app. It arises from the accumulated distrust in the taxi community that grew after the strikes against VTC users in 2018-2019 . The case has been studied before, and then, it has come to a solution that consists of an app that promotes transparency in the taxi sector and that adapts to the new consumer, creating a brand strategy and a communication plan for its launch.

2019
Grau en Publicitat i Relacions Públiques [972]  
9.
114 p, 2.1 MB Análisis sobre el éxito en la Industria Musical española del siglo XXI / Baño Pérez, Clara del ; Lorite García, Nicolás, dir. (Universitat Autònoma de Barcelona. Departament de Publicitat, Relacions Públiques i Comunicació Audiovisual) ; Universitat Autònoma de Barcelona. Facultat de Ciències de la Comunicació
Aparentment la música, com qualsevol producte que sorgeixi de les conegudes com a "indústries culturals", està subjecta a la subjectivitat de les audiències, és a dir: la reacció que el públic pugui tenir davant un artista musical és imprevisible independentment dels diners que s'inverteixi en seva estratègia de comunicació. [...]
Aparentemente la música, como cualquier producto que surja de las conocidas como "industrias culturales", está sujeta a la subjetividad de las audiencias, es decir: la reacción que el público pueda tener ante un artista musical es imprevisible independientemente del dinero que se invierta en su estrategia de comunicación. [...]
Apparently, music, like any product that arises from the so-called "cultural industries", is subject to the subjectivity of audiences, that is: the reaction that the public may have before a musical artist is unpredictable regardless of the money that is invested in Your communication strategy Everything within the music industry is relative. [...]

2019
Grau en Publicitat i Relacions Públiques [972]  
10.
69 p, 6.2 MB Digitalización en la ONG Afrikable y su entorno / Fragoso Pérez, Cristian ; Izaga Martínez, Ignacio, dir. ; Universitat Autònoma de Barcelona. Facultat de Ciències Econòmiques i Empresarials
El presente proyecto, motivado por la ejecución de la asignatura académica 'prácticas externas' en Lamu (Kenia) y con la finalidad de conocer más sobre esta economía emergente, quiere demostrar el funcionamiento de la ONG Afrikable y encontrar puntos de mejora, sobre todo, en la gestión y procesamiento de la información en el ámbito digital. [...]
2019
Grau en Empresa i Tecnologia [948]
2 documents

Research literature : 67 records found   1 - 10nextend  jump to record:
Learning materials 2 records found  
1.
11 p, 386.9 KB Pauta per a l'avaluació de la contribució individual dels membres al procés grupal en el treball en equip universitari / Agud Morell, Ingrid (Universitat Autònoma de Barcelona) ; Alcalde, Rosa ; Armengol Asparó, Carme ; Barrera-Corominas, Aleix ; Borras Izquierdo, Alexis ; Buñuel Azor, Immaculada ; Castro Ceacero, Diego ; Díaz Vicario, Anna ; Duran Bellonch, Maria del Mar ; González Fernández, Henar ; Ion, Georgeta ; Marzo Ruiz, Lourdes ; Mercader Juan, Cristina ; Muñoz Moreno, José Luís ; Orta Trepat, María ; Parera Garcia, Mònica ; Pérez-Maldonado, Cristina ; Rodríguez Gómez, David ; Salat Llorente, Esther ; Sánchez Martí, Angelina ; Zolle-Valero, Txell, col·laboradora
La pauta que es presenta a continuació parteix d'un projecte que es fonamenta en la necessitat d'assegurar una avaluació més individualitzada quan el mètode de treball escollit pel professorat és el treball en equip. [...]
Bellaterra 2018 (ARPA-Aula de Recursos per a l'Avaluació)  
2.
80 p, 3.4 MB An ARTisTIC trip : from Renaissance to Modern Times / Crous, Mariona ; Pérez, Carla ; Prat, Jaume ; Lobo Vírseda, Maria José, dir. ; Manau Santacana, Glòria, dir. ; CLILSI ; Content and Language Integrated Learning. Semiimmersió ; Universitat Autònoma de Barcelona. Facultat de Ciències de l'Educació
In this unit we will travel through time -going backwards and forwards- while talking about ART. We will visit Florence during the Renaissance and Florence today; we will meet Leonardo and Michelangelo but also contemporary artists; we will appreciate art and visit art galleries; we will get to know about inventions and discoveries; and last but not least, we will draw, play, act and even write using a secret technique.
Servei de Publicacions de la UAB 2012 (Learning English in Content-Rich Classrooms ; 2)
2 documents

Course materials 78 records found  1 - 10nextend  jump to record:
1.
4 p, 100.9 KB Recerca en Farmacologia Clínica [42151] / Antonijoan Arbós, Rosa María ; Agustí Escasany, Maria Antonieta ; Farré Albaladejo, Magí ; Ibáñez Mora, María Luisa ; Vidal Guitart, Xavier ; Pontes García, Caridad ; Perez Maña, Clara ; Universitat Autònoma de Barcelona. Facultat de Medicina
Aplicar els coneixements farmacològics i metodològics bàsics per desenvolupar la recerca clínica de fàrmacs i interpretar els resultats. Aplicar els coneixements farmacològics i metodològics bàsics per dur a terme una anàlisi crítica de la investigació clínica. [...]
Aplicar los conocimientos farmacológicos y metodológicos básicos para desarrollar la investigación clínica de fármacos e interpretar los resultados. Aplicar los conocimientos farmacológicos y metodológicos básicos para llevar a cabo un análisis crítico de la investigación clínica. [...]

2020-21
Màster Universitari en Investigació Clínica Aplicada en Ciències de la Salut [991]
3 documents
2.
4 p, 102.8 KB Mètodes de Recerca en Farmacologia Clínica [42360] / Diogène Fadini, Eduard ; Agustí Escasany, Maria Antonieta ; Alberola Domingo, Jordi ; Farré Albaladejo, Magí ; Ibáñez Mora, María Luisa ; Vidal Guitart, Xavier ; Romero Cereijo, Maria Dolors ; Pontes García, Caridad ; Perez Maña, Clara ; Universitat Autònoma de Barcelona. Facultat de Medicina
Aplicar els coneixements farmacològics i metodològics bàsics per desenvolupar la recerca clínica de fàrmacs i interpretar els resultats. Aplicar els coneixements farmacològics i metodològics bàsics per dur a terme una anàlisi crítica de la 1 Aplicar els coneixements farmacològics i metodològics bàsics per dur a terme una anàlisi crítica de la investigació clínica.
1 Aplicar los conocimientos farmacológicos y metodológicos básicos para desarrollar la investigación clínica de fármacos e interpretar los resultados. Aplicar los conocimientos farmacológicos y metodológicos básicos para llevar a cabo un análisis crítico de la investigación clínica.

2020-21
Màster Universitari en Farmacologia [1105]
3 documents
3.
7 p, 111.9 KB Funció del Cos Humà II [106098] / Penas Perez, Clara ; Muñoz Gall, Francisco Javier ; Velasco Fargas, Roser ; del Valle Macia, Jaume ; Delgado Martinez, Ignacio ; Sánchez Hidalgo, Antonio ; Durán Taberna, Montserrat ; Sánchez Corral, Ana ; Moral Cabrera, Raquel ; Herrando-Grabulosa, Mireia ; Universitat Autònoma de Barcelona. Facultat de Medicina ; Universitat Autònoma de Barcelona. Escola Universitària d'Infermeria de Sant Pau ; Universitat Autònoma de Barcelona. Escola Universitària d'Infermeria i de Fisioteràpia "Gimbernat" ; Universitat Autònoma de Barcelona. 506
L'assignatura Funció del Cos Humà II es anual i programa durant el primer curs del Grau d'Infermeria i desenvolupa el coneixement de la fisiologia de la sang i els òrgans hematopoètics, i el funcionament normal dels sistemes respiratori, cardiovascular, excretor, digestiu, endocrí i reproductor, i sistema nerviós. [...]
La asignatura Función del Cuerpo Humano II es anual y se programa durante el primer curso del Grado de Enfermería y desarrolla el conocimiento de la fisiología de la sangre y órganos hematopoyéticos y el funcionamiento normal de los sistemas respiratorio, cardiovascular, excretor, digestivo, endocrino y reproductor, y sistema nervioso. [...]

2020-21
Grau en Infermeria [1468]
Grau en Infermeria [1469]
Grau en Infermeria [1470]
Grau en Infermeria [1471]
3 documents
4.
4 p, 102.4 KB Mètodes Numèrics I [103950] / Flix Molina, José ; Pérez Dengra, Car ; Universitat Autònoma de Barcelona. Facultat de Ciències
En aquesta assignatura s'introdueiexen conceptes bàsics de la teoria de probabilitats i estadística, així com unes nocions fonamentals de programació en Python. La física és en últim terme una ciència experimental, basada en les mesures que es realitzen en experiments científics. [...]
En esta asignatura se introducen conceptos básicos de la teoría de probabilidad y estadística, así como unas nociones fundamentales de programación en Python. La física es en último término una ciencia experimental, basada en las medidas que se realizan en experimentos científicos. [...]

2020-21
Grau en Física [1281]
Grau en Física i Grau en Química [1287]
Grau en Física i Grau en Química [1434]
3 documents
5.
6 p, 108.3 KB Farmacologia en Fisioteràpia [102994] / Perez Maña, Clara ; Papaseit Fontanet, Esther ; Universitat Autònoma de Barcelona. Facultat de Medicina
L'assignatura és una optativa del tercer curs del Grau de Fisioteràpia. Es programa quan ja s'han assolit coneixements de Biologia, de Fisiologia i de Patologia Medicoquirúrgica. Els objectius formatius de l'assignatura consisteixen en mostrar les bases científiques en que es fonamenta el descobriment i la recerca dels medicaments en las seves fases preclínica i clínica. [...]
La asignatura es una optativa del tercer curso del grado de Fisioterapia. Se programa cuando ya se han alcanzado conocimientos de biología, de fisiología y de patología médico-quirúrgica. Los objetivos formativos de la asignatura consisten en presentar las bases científicas en las que se fundamenta el descubrimiento y la investigación de los medicamentos en sus fases preclínica y clínica. [...]

2020-21
Grau en Fisioteràpia [961]
3 documents
6.
7 p, 113.5 KB Avaluació Clínica en Fisioteràpia de l'Aparell Locomotor [102985] / Alier Fabrego, Albert ; Lopez Perez, Carlos ; González Lucena, Gema ; Universitat Autònoma de Barcelona. Facultat de Medicina
Els objectius generals de l'assignatura comprenen la valoració de l'aparell locomotor a partir de les dades clíniques obtingudes de l'anamnesi, la inspecció i l'exploració física. Es definiran els parámetres clínics de normalitat o anormalitat , que permetin elaborar una primera aproximació diagnòstica i una orientació terapèutica.
Los objetivos generales de la asignatura comprenden la valoración del aparato locomotor a partir de los datos clínicos obtenidos de la anamnesis, la inspección y la exploración física, basándose en la definición de parámetros de normalidad o anormalidad, que permitan elaborar una primera aproximación diagnóstica y una orientación terapéutica.

2020-21
Grau en Fisioteràpia [961]
3 documents
7.
9 p, 124.1 KB Patologia Estructural i Molecular [102927] / Romagosa Perez-Portabella, Cleofe ; Ariza, Aurelio ; Lerma Puertas, Enrique ; Navas Palacios, José Jerónimo ; Torres Ramírez, Inés Maria de ; Mate Sanz, José Luis ; García Jiménez, Angel ; Castellvi Vives, Jose ; Bella Cueto, Maria Rosa ; Ramon Y Cajal Agüeras, Santiago Jose ; Ferreres Piñas, Joan Carles ; Combalia Soriano, Maria Nieves ; Costa Trachsel, Irmgard ; Mozos Rocafort, Ana ; Lopez Vilaro, Laura ; Dinarès Fernández, M. Carme ; Peg Camara, Vicente ; Martinez Saez, Elena Antima ; Szafranska, Justyna Adolfina ; Fernandez Ruiz, Pedro Luis ; Tapia Melendo, Gustavo ; Escoda Giralt, Maria Rosa ; Salcedo Allende, Maria Teresa ; Casalots Casado, Alejandro ; Fuste Chimisana, Maria Victoria ; Universitat Autònoma de Barcelona. Facultat de Medicina
L'assignatura es programa a tercer curs del Grau de Medicina, que correspon a l'inici del període clínic, un cop s'han assolit els coneixements bàsics sobre l'estructura i funció del cos humà i abans d'introduir-se en l'estudi de les diferents patologies mèdiques i quirúrgiques i en la pràctica clínica. [...]
La asignatura se programa en tercer curso del Grado de Medicina, que corresponde al inicio del periodo clínico, una vez han adquirido los conocimientos básicos sobre la estructura y función del cuerpo humano y antes de introducirse en el estudio de las diferentes patologías médicas y quirúrgicas y en la práctica clínica. [...]

2020-21
Grau de Medicina [1192]
Grau en Medicina [960]
3 documents
8.
6 p, 113.5 KB Traducció B-A 1 (anglès-castellà) [101341] / Alcaina Pérez, Ana Carmen ; Gomez Goicoechea, Amaya ; Paradela López, David ; Universitat Autònoma de Barcelona. Facultat de Traducció i d'Interpretació
La funció d'aquesta assignatura es iniciar l'estudiant en la resolució de problemes de traducció de textos no especialitzats en llengua estàndard de diferents tipus (narratius, descriptius, conceptuals, argumentatius i instructius). [...]
La función de esta asignatura es iniciar al estudiante en la resolución de problemas de traducción de textos no especializados en lengua estándar de diferentes tipos (narrativos, descriptivos, conceptuales, argumentativos e instructivos). [...]

2020-21
Grau en Traducció i Interpretació [1202]
Grau en Traducció i Interpretació [1203]
Grau en Traducció i Interpretació [1204]
Màster Universitari en Traducció Audiovisual [1349]
Màster Universitari en Tradumàtica: Tecnologies de la Traducció [1350]
Master Universitario en Traducción y Estudios Interculturales [1401]
3 documents
9.
5 p, 109.7 KB Fisiopatologia i Regeneració de les Malalties Neurològiques [42910] / García Alias, Guillermo ; Aguilera Ávila, José ; Navarro Acebes, Xavier ; Casas Louzao, Caty ; Saura Antolin, Carlos Alberto ; Penas Perez, Clara ; Grup mort cel·lular, senescència i super, Victor J. Yuste Mateos ; Barcia Gonzalez, Carlos ; Flores de los Heros, Africa ; Bruna Escuer, Jordi ; Miñano Molina, Alfredo Jesús ; Quintana Romero, Albert ; Herrando-Grabulosa, Mireia ; Lopez Vales, Ruben ; Universitat Autònoma de Barcelona. Facultat de Biociències
Aquest mòdul ofereix una visió actualitzada dels processos implicats en la neurodegeneració i neuroregeneració en el sistema nerviós. El mòdul cobreix els mecanismes cel·lulars i moleculars subjacents a les malalties neurodegeneratives , analitzant l'etiopatogènia d'aquestes malalties així com el desenvolupament de teràpies racionals. [...]
Este módulo ofrece una visión actualizada de los procesos implicados en la neurodegeneración y neuroregeneración en el sistema nervioso. El módulo cubre los mecanismos celulares y moleculares que subyacen a las enfermedades neurodegenerativas, analizando la etiopatogenia de estas enfermedades así como el desarrollo de terapias racionales. [...]

2020-21
Màster Universitari en Neurociències [1158]
3 documents
10.
4 p, 100.8 KB Sistemes d'Informació [104728] / Sebastián Pérez, Juan Carlos ; Universitat Autònoma de Barcelona. Facultat de Ciències de la Comunicació
1. Conèixer les bases de les infraestructures de les tecnologies de la informació. 2. Conèixer els diferents tipus d'infraestructura de xarxes i el seu funcionament. 3. Aprendre l'arquitectura dels sistemes informàtics. [...]
1. Conocer las bases de las infraestructuras de las tecnologias de la información. 2. Conocer los diferentes tipos de infraestructura de redes y su funcionamiento. 3. Aprender la arquitectura de los sistemas informáticos. [...]

2020-21
Grau en Comunicació Interactiva [1423]
3 documents

Course materials : 78 records found   1 - 10nextend  jump to record:
Graphic and multimedia documents 1 records found  
1.
54:36, 50.0 MB Allez, Allez !". Camps d'internament / Cassanyes, Enric ; Pérez, Conxa ; Catalunya Ràdio
Veus de l'exili (Programa radiofònic)
2006 (Veus de l'exili ; 3)  

Personal and institutional archives 3 records found  
1.
1 p, 699.7 KB Carta de Carlos Gámez Pérez (CEHIC, Universitat Autònoma de Barcelona) a Pere Pascual demanant-li informació sobre el GIFT per a la elaboració de la seva tesi doctoral / Gámez Pérez, Carlos, 1969- ; Pascual, Pedro, 1934-2006
2000  
 UAB restricted access
2.
21 p, 4.2 MB Homenaje a Joaquín Rodrigo / Corbella, Luis ; Gómez, Pura ; Pergolesi, Giovanni Battista ; Pérez Durias, Carmen ; Rodrigo, Joaquín ; Toldrà i Soler, Eduard ; Torrentó, Lolita ; Yepes, Narciso ; Orquestra del Gran Teatre del Liceu ; Societat del Gran Teatre del Liceu
Barcelona : 1952 (Temporada de cuaresma 1952)  
3.
2 p, 3.1 MB José Agustín Goytisolo, poeta industrial / Pérez Cavero, Carlos
23 novembre 1978  

See also: similar author names
1 Perez, Clotilde
1 Perez, Cynthia C.
1 Pérez, Camila
1 Pérez, Carla
3 Pérez, Carlos
4 Pérez, Carmen
2 Pérez, Catherine
1 Pérez, Catherine,
1 Pérez, Cecilia
1 Pérez, Conxa
1 Pérez, Coralie
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.